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General Abstract 
Coordinated gastrointestinal (GI) motility results from the 
I 
complex interactions between interstitial cells of Cajal (ICC), 
enteric neurons, and smooth muscle cells. Kit positive 
immunoreactivity has been extensively utilized as a marker for 
ICC; these cells function to generate rhythmic depolarization in 
the GI smooth muscle termed the electrical slow wave. 
Coordinated GI motility is regulated by the electrical slow wave. 
Directly lesioning ICC populations with neutralizing antibodies 
results in GI dysmotility and loss of the electrical slow wave. 
Furthermore, GI dysmotility symptoms and other human pathologies 
have been correlated with ICC deficiencies within the GI tract. 
Currently, there are few treatments and therapeutic 
interventions for GI motility disorders, Irritable Bowl Syndrome 
alone affects up to 20% of the world population. 1- 5 The high 
prevalence of GI motility disorders combined with the lack of 
effective interventions, suggest new treatments are needed. 
Rational drug development and new treatment design will benefit 
from the development of new model systems. Greater understanding 
of the regulation of GI motility, pathologies that affect GI 
motility, and the development of new therapeutics will all 
benefit from a new model of GI motility. 
1 
2 
This thesis provides support to the use of Danio rerio, the 
zebrafish, as a model of human GI motility. Danio rerio is an 
excellent model system for several human physiological systems or 
diseases including macular degeneration, neural degenerative 
diseases, cardiovascular disease, cholesterol and lipid 
metabolism, and cardiovascular disease. 6- 20 
The zebrafish model system offers the opportunity for 
forward genetic analysis; novel genes, genetic elements, and 
pathologies can be characterized with reverse genetic screens 
through the evaluation of interesting phenotypes. Zebrafish 
reach sexual maturity quickly (three months), produce large 
numbers of offspring (100 per week), and are more cost efficient 
to house compared to mammalian models. Most seductive of 
zebrafish traits, optical transparency of larvae, enables direct 
visualization in-vivo of organ function (including the GI tract) 
under physiological settings, without perturbing the organism. 
This thesis critically examines the hypothesis that GI 
motility in the zebrafish involves ICC. Prior to the data 
presented within this thesis, there have not been any published 
reports on the presence of ICC within the zebrafish GI tract. 
Results from this investigation show Kit-like immunoreactivity 
within the muscular layers of the zebrafish GI tract. 
Additionally, orthologs for the human receptor tyrosine kinase 
3 
Kit, kita and kitb, and orthologs for the human Kit ligand, kitla 
and kitlb, are shown to be expressed within the zebrafish GI 
tract. Kit receptor and ligand are necessary for ICC development 
and maintenance in mammals. Expression of kit receptors and 
ligands within the zebrafish GI tract are consistent with the 
hypothesis that ICC support spontaneous rhythmic contractions in 
the zebrafish-- this suggests that the zebrafish may be a 
suitable model for GI motility. 
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General Introduction 
I 
The gastrointestinal (GI) tract of higher vertebrates is 
specialized to digest and absorb nutrients for cellular 
metabolism. The GI tract is organized in concentric rings of 
tissue, each with specialized functions. Food is chemically and 
mechanically digested in the luminal space; this space is at the 
center of the concentric rings of tissue that make up the GI 
tract. The four primary layers of the digestive tract, moving 
from the lumen to the interior of the body 1 are the mucosa, 
submucosa, muscularis externa, and the serosa. The anatomy and 
the function of these layers will be briefly described (also see 
figure 1 and figure 2). 
After food is broken-down into "absorbable" units it is 
transported into the mucosa via active and passive transport 
mechanisms. The mucosa consists of the mucosal epithelium~ an 
underlying layer of connective tissue termed the lamina propia, 
and a thin layer of smooth muscles termed the muscular mucosa. 
The mucosal epithelium is a complete barrier separating luminal 
contents from the body, and consists of enterocytes (absorptive 
cells), goblet cells that secrete mucins, M-cells that transport 
pathogens to the immune system, and exocrine cells that secrete 
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Figure 1. 20X transverse section of the zebrafish GI tract stained with 
hematoxylin and eosin. 
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Figure 2. 40X transverse section of the zebrafish GI tract stained with 
hematoxylin and eosin. 
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fluid and digestive enzymes into the luminal space. Moving from 
the mucosa towards the muscular layer of the GI tract, the lamina 
propia is a layer connective tissue that consists of blood 
vessels, neural processes, immune cells, and blunt ended lymph 
ducts (lacteals). A thin layer of smooth muscle cells, the 
muscularis mucosa, underlies the lamina propia and functions to 
mix and churn the luminal contents, enhancing absorption. The 
mucosa, consisting of mucosal epithelium, the lamina propia, and 
the muscular mucosa, is organized into finger-like structures, 
villi, that project into the luminal space. Absorbed nutrients 
are transported from entrocytes to veins in the lamina propia, 
which empty into the hepatic portal vein. Thus, molecules 
absorbed by the GI system travel directly to the liver for 
detoxification, and subsequently enter the systemic circulation. 
The submucosa is a relatively thick layer of connective 
tissue containing blood vessels, lymphatic vessels, and immune 
cells. The muscularis externa is positioned interior to the 
submucosa, and consists of an inner circular and an outer 
longitudinal muscular layer. Rhythmic muscular contraction, 
motility, is partially controlled by the enteric nervous system 
with cell bodies located within the submucosal and the myenteric 
plexus. The submucosal plexus separates the circular muscle 
layer from the submucosa, and the myenteric plexus separates the 
circular from the longitudinal muscle layers. Interstitial cells 
of Cajal (ICC) and enteric neurons populate each plexus and 
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function together to coordinate GI smooth muscle coQtractions. 
Effective and efficient motility results from complex motor 
patterns developed by enteric neurons and by ICC. These 
coordinated contractions, referred to as GI motility, can be 
classified as propulsive or mixing. Motility displays circadian 
rhythms, and is different in the fasted and the fed (post-
prandial) states. During the fasting state powerful waves of 
contraction propagate aboraly to 'cleanse' the bowel, preventing 
microbial overpopulation. The outermost layer, the serosa (or 
adventitia) is a connective tissue layer that serves to hold the 
GI tract in place within the abdominal-pelvic cavity. The serosa 
protects the GI tract, supports fragile blood vessels, afferent 
sensory and efferent autonomic nerves, and lymphatic ducts. 
Three basic cell types, often termed the intestinal triad, 
are necessary for proper GI motility: smooth muscle, enteric 
neurons, and ICC. Smooth muscle cells (circular and 
longitudinal) are the force generating, contractile cells, 
necessary for intestinal motility. Contractions of longitudinal 
smooth muscle cells shorten GI tract length, while circular 
smooth muscle contraction narrows the lumen, resulting in 
segmentation. Stretch receptors activated by mechanical stimuli 
and chemical receptors monitor luminal content, and transmit 
information to the enteric nervous system. The peripheral 
autonomic nervous system also influences the enteric nervous 
system via the parasympathetic neurotransmitter acetylcholine and 
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sympathetic neurotransmitter epinephrine. It is important to 
recognize that neurotransmitters also influence ICC activity, and 
that ICC integrate and amplify signals from the enteric nervous 
system. Spontaneous and rhythmic activity occurs in the GI 
tract, and results in regular waves of contractions that propel 
the contents of the gut in an aboral direction. ICC are required 
for ordered propulsion. A change in the resting membrane 
potential of ICC and smooth muscle cells, termed the electrical 
slow wave, is correlated with regular muscular contraction. ICC 
regulate the frequency and strength of these contractions, and 
form a network within the myenteric plexus region, which 
functions to distribute and propagate neural input along the 
length of the GI tract. Clinical dysmotility in humans, such as 
constipation, Hirschsprung's disease, intestinal 
pseudoobstruction, as well as diabetic gastroparesis are 
correlated with reduced numbers of ICC and/or enteric neurons. 
Treatment options for individuals with GI dysmotility are 
very limited, yet up to 20% of the world population has just one 
classification of GI dysmotility, Irritable Bowl Syndrome. 1- 4 
However, GI dysmotility remains a large unmet medical problem, 
and represents a huge opportunity for the pharmaceutical 
industry. In the face of opportunity, GI motility research still 
,Poses several very difficult barriers to drug discovery. For 
example, an intact intestinal triad would ideally be used to 
screen potential compounds, but this is experimentally difficult. 
Merely taking the GI tract out of an animal disturbs the GI 
tract, causing gastroparesis and inflammation. Cell culture of 
the complete intestinal triad is challenging, and ICC undergo 
morphological changes in culture. The paucity of treatment 
options and success in drug discovery for GI dysmotility 
therapeutics suggest new model systems are needed. 
12 
The zebrafish has many advantages over previous models 
utilized in GI drug discovery. Zebrafish have been traditionally 
used as a developmental model because larvae are optically 
transparent and development occurs quickly. The GI tract of 
zebrafish larvae can be observed with light microscopy, which 
allows for the observation of the entire GI system in a non-
perturbed state. Additional advantages of the zebrafish model 
are as follows: the zebrafish can absorb small drug molecules 
transdermally, which may enable high-throughput-automated 
screening of combinatorial libraries; transgenic zebrafish are 
relatively easy to generate due to external fertilization and 
development of embryos; random mutagenesis followed by phenotype 
screening can be used to identify novel genes; fecundity is high 
with 70-300 offspring per pair of zebrafish; and zebrafish 
colonies ·are very inexpensive to maintain. 
The first step to develop a zebrafish model for GI motility 
is to determine if the basic cellular components {ICC, enteric 
neurons, and smooth muscle) are present within the GI tract of 
the zebrafish, and if these components display similar anatomical 
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organization to the human GI tract. Preliminary data, generated 
by Dr. Adam Rich, indicated Kit-like immunoreactivity within 
whole mount preparations of adult and larvae (7dpf) zebrafish GI 
tracts. The Kit-like immunoreactivity localized to the GI tract 
and appeared to be organized in a network. Additionally, kita 
message of expected size was amplified from GI tissue via reverse 
transcriptase PCR; these data suggest the presence of ICC within 
the zebrafish GI tract. Kit immunoreactivity is the standard 
marker for identification of ICC. However, anatomical 
localization of ICC within the zebrafish GI tract or their 
relationship to enteric neurons and smooth muscle has not been 
established. It is possible that the Kit-like 
immunohistochemistry localized to a novel zebrafish protein 
correlating to a novel cell type. Therefore, it is important to 
verify preliminary data and to show the anatomic position of Kit-
positive cells in relation to smooth muscle and enteric neurons. 
The primary objective of this thesis is to determine if 
Kit-positive pacemaker cells, putative interstitial cells of 
Cajal, are present within the tunica muscularis of the zebrafish 
GI tract. Expression of kit genes within the tunica muscularis 
of the GI tract will be examined using anti-Kit antibodies. No 
zebrafish-specific anti-Kit antibodies are available; therefore, 
several commercially available anti-Kit antibodies will be 
examined. These antibodies have been raised against human Kit, 
mouse Kit, or synthetic peptides with sequences based on human 
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Kit. Expression of zebrafish kit genes will also be examined at 
the mRNA level. Specific expression of the zebrafish orthologues 
of human Kit, kita and kitb, as well as the Kit ligand (Steel 
factor), kitla and kitlb, will be determined in GI tissues; these 
experiments will complement the antibody experiments, and will 
test for the presence of kit expression within the zebrafish GI 
tract independent of antibody staining. Independent 
corroboration of kit expression is necessary because of the 
possibility that the anti-Kit antibody could identify an antigen 
unrelated to Kit. Kit-positive cells within the tunica 
muscularis of the zebrafish GI tract are expected to localize to 
an intermediary position, juxtaposed between enteric neurons and 
smooth muscles of the GI tract, the localization of human GI 
tract ICC. Anti-Kit antibodies and anti-neuronal or anti-smooth 
muscle antibodies will be used in dual staining experiments to 
define anatomical localizations. 
Several techniques were developed for experiments within 
this thesis. First and foremost, an antigen retrieval technique 
was developed to optimize kit antibody labeling. This was 
necessary because initial attempts showed inconsistent results 
and poor labeling. This technique enhanced kit labeling and was 
used for all sectioned tissues; these results are given in 
Chapter 1: Antigen Retrieval. Immunohistochemical analysis of 
transverse sections required paraformaldehyde fixation, paraffin 
embedding, and transverse sectioning of GI tissues. Transverse 
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sections are well-suited to determine the anatomical orientation 
of Kit-positive cells with respect to layers of smooth muscle and 
enteric neurons. The simultaneous application of two primary 
antibodies, termed dual labeling, revealed the precise 
organization of Kit-positive cells and smooth muscles or enteric 
neurons in transverse tissue sections; these results are given in 
Chapter 2: Immunohistochemistry. If the anti-Kit antibody 
specifically recognizes the zebrafish kit proteins, mRNA for the 
kit genes should be expressed within zebrafish GI tissues. 
Reverse transcriptase polymerase chain reaction (RT-PCR) was 
utilized to identify two zebrafish Kit orthologues, kita and 
kitb, as well as the ligands for these receptors, kitla (kit 
ligand a) and kitlb (kit ligand b); these results are given in 
Chapter 3: Molecular Biology. 
The data presented in this thesis show that cells with Kit-
like immunoreactivity are located within the tunica muscularis of 
the zebrafish GI tract, and that these cells are positioned in 
the myenteric plexus region, intercalated between enteric neurons 
and smooth muscle cells. Also, GI specific expression of the 
zebrafish kita, kitb, kitla, and kitlb genes are shown. Taken 
together these data strongly support the presence of ICC within 
the muscular layers of the zebrafish GI tract. 
16 
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General Experimental Approach and 
Cross-sections of the zebrafish allow for simultaneous-
unobstructed visualization of each layer of the GI tract. The 
anatomical location of the intestinal triad within the zebrafish 
GI tract was determined using transverse sections immunostained 
with antibodies specific to Kit (human/mouse ICC marker), desmin 
(smooth muscle marker), SM-22 (smooth muscle marker), a-tubulin 
(neuronal process marker), and HU-C/D (neuronal cell body 
marker) . 
Initial staining of paraffin-embedded sections with the 
anti-Kit antibody showed punctuate and non-continuous staining. 
However, whole mount staining of tissue with the anti-Kit 
antibody was more consistent. These results indicated that 
immunostaining artifacts were introduced by the paraffin-
embedding and sectioning. A literature search showed that this 
problem is common in routine immunohistochemistry. Antigen 
retrieval, a technique that 'unmasks' antigens that have been 
negatively affected by paraffin-embedding, was applied to 
sections prior to immunostaining to restore immunoreactivity of 
the anti-Kit antibody target. The results were more consistent 
16 
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staining with the anti-Kit antibody. Smooth muscle and neuronal 
staining patterns were not affected by the retrieval method; this 
advance instigated ubiquitous use of antigen retrieval on all 
paraffin-embedded sections prior to immunostaining'. 
Single staining with anti-Kit antibody indicated two 
distinct cell layers with Kit-like immunoreactivity within the GI 
tract of the zebrafish. To determine if observed Kit-like 
immunoreactivity was localized to the myenteric plexus region, 
smooth muscle stains were used in concert with Kit-like staining. 
Both desmin and SM-22 staining define two layers of smooth 
muscle, but desmin appears to stain with higher resolution. Dual 
staining for desmin and Kit revealed Kit-like immunoreactivity 
localized between the two layers of smooth muscle (myenteric 
plexus region). Additionally, a second layer of Kit-like 
immunoreactivity colocalized with circular muscle cells adjacent 
to the myenteric plexus region, indicating a layer of ICC within 
the deep muscular plexus (similar to the human colon). 
Neuronal staining of cross-sections of the zebrafish GI 
tract indicated a single layer of neuronal cell bodies and three 
distinct layers of neuronal processes. Cell bodies of enteric 
neurons localized to the myenteric plexus region and localized 
very close to Kit-like immunoreactivity in dual staining 
experiments. Neuronal processes localized to the myenteric 
plexus region, the deep muscular plexus region, and also to the 
lacteal region of the mucosal layer of the GI tract. The neural 
process staining was closely associated with Kit-like 
immunoreactivity in the all regions with the exception of the 
lacteal region. 
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Whole mount sample corroborated sectioned tissue data; Dual 
staining with anti-Kit and anti-neuron antibodies indicated that 
Kit-like immunoreactivity closely associated, but did not 
colocalize to the same cell type. Staining with anti-Kit and 
anti-smooth muscle antibodies showed that Kit-like 
immunoreactivity occurred strongly between the circular and 
longitudinal smooth muscle layers (the myenteric plexus), and 
also indicated more subtle Kit-like immunoreactivity tangential 
to the circular smooth muscle/myenteric plexus border region 
(deep muscular plexus). Additionally, whole mount samples 
indicated that cells within the myenteric plexus region cells 
displaying Kit-like reactivity were of classical cellular 
morphology for myenteric ICC (stellate shaped cells with wide 
cell bodies and multi polar processes). Cells displaying Kit-
like immunoreactivity within the deep muscular plexus also 
displayed classical cellular morphology of deep muscular ICC 
(slender bi polar cells, with distinct ovular cell bodies). 
To support the notion that Kit-like reactivity is 
recognizing zebrafish kit receptors and, thus, ICC populations, 
the ligands for the kit receptors were identified in adult 
zebrafish GI tissue. A reverse transcriptase PCR approach using 
RNA isolated for GI tissues as template was utilized to determine 
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expression of kital and kitbl, co-orthologus pairs of the Steel 
factor, the mammalian Kit ligand; PCR products were sequenced for 
verification. The results of these experiments showed that the 
factors necessary for the stimulation of the kit receptors are 
expressed within zebrafish GI tissues. 
In summary, Kit-like immunoreactivity was observed within 
the tunica muscularis of the zebrafish GI tract, with 
localization similar to ICC populations within mammalian and 
human GI tracts. Kit-like immunoreactivity was closely 
associated with neuronal staining of cell bodies and processes, 
which is also consistent with mammalian and humans GI tract 
organization. The close association of ICC and neurons suggests 
a conserved structure-function relationship; Thus, ICC within the 
zebrafish GI tract may function as integrators of neural 
information for pacemaking regulation of smooth muscle cells. 
ICC require Kit ligand for development and maintenance in the 
mouse model; enteric neurons within the mouse GI tract may be an 
important source for Kit ligand. Immunohistochemical 
localization of ICC is supported by reverse transcriptase PCR, 
which detected the presence of mRNA coding for the kit receptors 
and for the kit ligands; both factors are necessary for ICC 
development and maintenance in other model systems. Data 
presented in this thesis supports the existence of ICC within the 
zebrafish GI tract, and supports ICC within the zebrafish GI 
tract as regulators of coordinated GI motility; the data 
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presented in this thesis supports the zebrafish as a complete and 
important model system for human GI motility. 
Materials and Methods 
1. Introduction 
Detailed methods of each procedure used in this thesis are 
outlined in Appendix 1: Protocols. Within this section, research 
approaches will be detailed and specific procedures, Appendix 1: 
Protocols, will be citied. To complement Appendix 1: Protocols, 
this section will be broken up into related methods to aid 
clarity and transparency of this investigation. Protocols 
describing solution and media preparation will be separate from 
general protocols. 
2. Whole fish, larvae, or adult tissues to thin 
paraffin tissue sections 
This section contains an overview of the procedures 
necessary to process adult or larva zebrafish into thin sections 
of paraffin-embedded tissue. This process includes: euthanizing 
and dissection of fish, fixation and decalcification of samples, 
tissue processing and embedding, and finally tissue sectioning 
(Flowchart 1) . 
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3. Immunohistochemistry 
The overview of protocols in this section will deal with 
the staining of tissues with antibodies to localize proteins of 
interest. This overview assumes that thin sectioned tissues are 
mounted on charged glass slides, and whole mount tissues have not 
been previously fixed. 
The choice of short or long immunostaining protocol does 
not alter staining intensity o~ specificity; time restraints are 
the largest influencing factor when deciding between long or 
short immunostaining protocols. 
The use of antigen retrieval is optional for 
• immunostaining, it may improve or have deleterious effects on 
immunostaining staining; thus, it is important to test a battery 
of different antigen retrieval solutions, and only use antigen 
retrieval if immunostaining on non-retrieved samples fails 
repeatedly. Details on antigen retrieval are discussed in 
Chapter One: Antigen Retrieval. 
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4. RNA Isolation to eDNA 
This section will provide an overview of the procedures 
necessary to generate eDNA from tissue samples. RNA isolation, 
RNA purity measurements, RNA concentration measurements, RNA 
integrity measurements, and first strand synthesis will be 
addressed; the combination of these procedures will yield high 
quality DNA for downstream applications . 
• 
26 
27 
Figure 3. RNA isolation to eDNA 
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5. PCR Protocols 
This section will cover protocols necessary to optimize PCR 
conditions of novel primer sets. Additionally, general 
procedures for PCR will be addressed. These procedures include 
both high fidelity DNA polymerase PCR, such as PFX (Invitrogen), 
utilized for cloning, and Supermix (Invitrogen) PCR protocols, 
utilized for confirmation of DNA sequences based on product size . 
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6. DNA Sequencing 
This section contains an overview of the direct sequencing 
of PCR products, and the sequencing of PCR products that have 
been subcloned into vectors. This section assumes that gene 
specific PFX PCR has been completed, specificity of PCR has been 
confirmed through agarose gel electrophoresis, and PCR sample has 
been reserved for sequencing. Finally, this section assumes that 
sample will be sent to Cornell Biotechnology Center (Ithaca, NY) 
for sequencing. 
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General Formatting 
This thesis was formatted into three distinct chapters for 
the purpose of aiding the reader in understanding the distinct 
approaches utilized in the generation of this body of this work, 
and for future publication considerations. Chapter 2: 
Immunohistochemistry, has been accepted for publication, and is 
included as a reprint of the original published article. General 
sections were included to provide a cohesive overview of the 
goals, materials and methods, and though~ process involved in 
this thesis. Three appendices were included as reference sources 
• 
for future lab members, and to include supplemental data for 
completeness. 
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Chapter 1: Antigen Retrieval 
gptimization of Kit-like immunoreactivity within the zebrafish 
gastrointestinal tract through antigen retrieval. 
Scott Leddon 
Department of Biological Sciences 
State University of New York College at Brockport 
Brockport, New York 
• 
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Abstract 
Kit immunoreactivity is the most common and efficient way 
to visualize interstitial cells of Cajal (ICC) . 1- 7 ICC function 
as regulators of gastrointestinal (GI) slow wave propagation and 
are essential for coordinated contraction of the GI tract. 8• 9 
Deficiencies in ICC populations in humans have been observed in 
diabetic gastroporesis, irritable bowl syndrome, Hirschsprung's 
disease, and other motility disorders. 10- 14 Routine fixing 
procedures often mask ICC antigen recognition sites for primary 
antibody binding; therefore, antigen retrieval techniques are 
sometimes essential for consistent immunostaining. Several 
antigen retrieval methods ~ere assayed to optimize conditions for 
paraformaldehyde-fixed paraffin-embedded zebrafish GI tissues 
with the anti-Kit polyclonal antibody, ab16832 (Abeam). 
1. Introduction 
Interstitial cells of Cajal (ICC) propagate the electrical 
slow wave throughout the gastrointestinal (GI) tract smooth 
muscle, which functions to regulate and coordinate smooth muscle 
contraction. 8• 9 ICC are necessary for coordinated motility of the 
GI tract, and many motility disorder in humans display lesions in 
ICC populations. 10- 14 ICC express the receptor tyrosine kinase 
Kit, and require Kit signaling for maintenance and survival. 9 
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Kit immunohistochemistry is the most simple and commonly accepted 
manner in which to visualize and analyze ICC populations. 1- 7 
Initial attempts at Kit Immunohistochemical localization of ICC 
within zebrafish paraformaldehyde fixed paraffin-embedded GI 
tissues failed. This initial failure to visualize Kit 
immunohistochemistry within the zebrafish GI tract led us to 
believe the Kit antigen was paraformaldehyde sensitive, and would 
need optimized antigen retrieval conditions for consistent 
immunohistochemical staining. 
Formalin-based fixed paraffin-embedded tissue is the most 
commonly used method to preserve tissue morphology by both 
clinicians and researchers. Tissue fixation is thought to occur 
primarily due to protein cross-linking. Formalin-based fixation 
is theorized to be a two-step reaction: addition of the aldehyde 
• to a primary amino group forming an iminium intermediate, which 
then reacts with an electronegative carbon on an adjacent amino 
acid resulting in the loss of water and cross-linking of residues 
(figure 1) . 15 Cross-linking of amino acid residues can result in 
subtle alterations of tertiary protein structure, which is 
thought to be the primary cause of loss of antigen 
immunogenicity. 
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Advances in histology have yielded many techniques to 
restore immunogenicity of antigens in formalin-based fixed 
tissues ; these procedures are commonly referred to as antigen 
retrieval or antigen unmasking. Antigen retrieva l techniqu es aim 
to break amino acid cross - linking through hydrolysis and 
denaturation of proteins . Non-enzymatic antigen retrieval 
techniques aim to break or lessen the effects of amino acid 
cross-links induced by aldehyde based fixation. The breaking or 
loosing of aldehyde induced prote in cross-links is accomplished 
primarily through common methods of protein denaturation : high 
temperatures , differential ionic, and altered pH conditions . 
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Additional non-enzymatic antigen retrieval modi operandi include: 
rehydration of tissue, precipitation of soluble proteins, removal 
of residual traces of paraffin from tissue post 
deparaffinization, reversal of Schiff bases induced by aldehyde 
based fixatives, and disruption of salt/protein complexes that 
can form during tissue fixation. 16- 22 Enzymatic antigen retrieval, 
on the other hand, utilizes proteases to break limited numbers of 
peptide bonds, which can relive fixation induced conformational 
changes within the protein due to cross-linking. Additionally, 
protease mediated antigen retrieval may restore antigenicity by 
increasing tissue permeability through the digestion of 
extracellular and membrane bound proteins. 23 Optimal retrieval 
techniques are antigen and fixation specific. Important 
variables that must be optimized include time, pH, temperature, 
heating method, and retrieval solutions. This paper defines 
optimal antigen retrieval methods for immunostaining 
paraformaldehyde-fixed paraffin-embedded zebrafish GI tissues 
with the anti-Kit polyclonal antibodY., abl6832 (Abeam). 
2. Materials and Methods 
2.1.a Tissue 
Adult wild type zebrafish (AB strain, obtained from the 
Zebrafish International Resource Center, .ZIRC) were fixed in 4% 
paraformaldehyde (PF) in lX PBS (Fisher Scientific; Pittsburgh 
PA) overnight at 4°C on a rotating platform with heads and tails 
removed. Gastrointestinal tracts were dissected, washed in lX 
PBS, and placed in 70% ethanol. Tissues were processed with a 
Tissue-Tek VIP on a 12 hour protocol, and dissected into 
anterior, middle, and posterior segments prior to paraffin 
embedding. Tissues were sectioned at 4um and placed on 
commercially prepared charged slides (Fisher Scientific; 
Pittsburgh PA) . Slides were baked at 56°C overnight prior to 
antigen retrieval . 
.. 
2.2. Antigen retrieval solutions 
Several solutions were tested for suitable antigen 
retrieval. Citraconic acid antigen retrieval solution is 0.05% 
citraconic anhydride in deionized water (pH 7.4). Citrate 
antigen retrieval solution is lOmM tri-sodium citrate dehydrate 
and 0.05% Tween 20 in deionized water (pH 6.0). Proteinase K 
antigen retrieval solution is 20pg/mL proteinase K in TE buffer 
Table 1. Compqsition ofAntigen Retrieval Solutions 
Citraconic acid O.O.S%citnu:onic anhydride in dH~,pH 7.4 
Citrate lOniMtri-sodium~ dehydrate~ 0.0.5% Tween 20 in dll:lO. 
Proteinase K. 
Abeam (ab973) 
Dako (82369) 
pH6.0 
20J1gfmL proteinase K in TE buffi:r1. pH 6.0. 1E buflCr is .SOniM 
trisbase and 1D'iMEDTA in dBp. pH 8.0 
1:10 dilutio.nofcq~ availahlc· lOX solution in dH~ 
1:10 dilution ofoo.mmc:R:ially available lOX solution indH~ 
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(pH 6.0). TE buffer is 50mM tris base and lmM EDTA in deionized 
water (pH 8.0). Abeam and Dako commercially available antigen 
retrieval solutions were diluted to manufacture recommended 
concentrations with deionized water; both solutions are supplied 
at lOX concentrations. 
2.3. Antigen retrieval conditions 
Tissue sections were de-paraffinized with xylene and 
rehydrated through an ethanol gradient, ending with deionized 
water. Tissue was then placed in 100°C antigen retrieval 
solution for 20 minutes. Tissue, still in antigen retrieval 
• 
solution, was allowed to cool for 20 minutes at room temperature. 
Samples were then was washed in two changes of phosphate buffered 
saline with 0.1% Triton X-100 and 0.05% Tween 20 (PBSTT) for 5 
minutes each. Control tissue was placed in room temperature 
PBSTT instead of 100°C antigen retrieval solution. Proteinase K 
antigen retrieval differs from the other retrieval methods due to 
its proteolytic modus operandi. Post rehydration, proteinase K 
retrieved samples were placed in freshly prepared 37°C proteinase 
K antigen retrieval solution for 10 minutes; following 37°C 
incubation, samples were allowed to cool for 10 minutes at room 
temperature, and then were washed in two changes of PBSTT for 5 
minutes each. 
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2.4. Immunohistochemistry 
Tissue was blocked with 10% normal donkey serum (NDS) in 
PBSTT for 1 hour at room temperature, followed by incubation with 
Abeam 16324 1:100 (5% NDS in PBSTT) for one hour at room 
temperature. Tissue was washed in two changes of PBSTT for 5 
minutes each prior to the application of donkey anti-rabbit IgG 
conjugated to Cy3 1:400 (2.5% NDS in PBSTT) for one hour at room 
temperature. Tissue was then washed in two changes of PBSTT for 
5 minutes each. Slow Fade (Molecular Probes) was then applied 
before coverslipping. Fluorescence images were collected on an 
upright Olympus BX-51 using a Q-imaging 12-bit cooled CCD camera 
and Image Pro Plus· software (Media Cybernetics). 
2.5. Qualitative Evaluation of Antigenicity Restoration 
Fluorescent images were blindly evaluated for qualitative 
restoration of antigenicity on the bases of immunohistochemical 
reactivity, nonspecific background staining, tissue integrity, 
and uniformity in staining (Table 2). Samples which display 
qualitative increases in Kit-like immunohistochemistry and 
nonspecific background staining levels comparable to non-
retrieved samples are referred to as having an increased signal 
to noise ratio. 
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3. Results 
Kit immunohistochemistry has been used in many vertebrate 
model systems to identify interstitial cells of Cajal in the 
gastrointestinal (GI) tract. 2 Initial immunohistochemical 
analysis of Kit-like immunoreactivity of 4% paraformaldehyde 
fixed, paraffin-embedded tissue sections of adult zebrafish 
gastrointestinal tracts yielded negative results. However, these 
results were inconsistent with reverse transcriptase polymerase 
chain reaction performed on total RNA isolated from adult 
zebrafish GI tissues (Chapter 3: Molecular Biology). Further, 
Kit-like immunoreactivity was observed in whole-mount tissue 
preparations from adult zebrafish GI tract. Therefore, we used 
• 
antigen retrieval techniques to test the possibility that antigen 
masking artifacts on paraffin embedded sectioned tissues 
interfered with Kit-like immunohistochemical analysis. 
Five separate antigen retrieval solutions were compared, 
two commercially available and three commonly used. Each 
solution was assayed for the ability to enhance 
immunohistochemical staining of putative ICC, nonspecific 
background staining levels, tissue integrity post retrieval, and 
degree of uniformity in staining. The effect of proteinase K on 
Kit-like immunoreactivity was also determined. 
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Kit-like immunoreactivity is predicted to localize to the 
muscularis externa, the muscular outer layer of the GI tract, 
where ICC functionally determine the frequency and magnitude of 
smooth muscle contractions (see figure 2 and figure 3 for area of 
predicted kit-like immunoreactivity). More specifically, a high 
density of ICC are expected to populate the myenteric plexus 
region between the longitudinal and circular smooth muscle 
layers, similar to the mouse, guinea pig, canine, equine, and 
human. 9• 10 ICC have also been observed in high density within the 
deep muscular plexus, a thin band of smooth muscle adjacent to 
the superficial border of the circular smooth muscle, and 
interspersed within the smooth muscula~ layers. 24 
Smooth muscle layers of the zebrafish GI tract are 2 -8 
cell layers thick, and ICC are expected to populate a 1 cell 
layer-network in the myenteric plexus region. The zebrafish 
smooth muscle layers are thin when compared to humans and other 
mammalians models; therefore, ICC may not be necessary to amplify 
and propagate the electrical slow wave across the smooth muscle 
layers. ICC within the circular muscle layer function to amplify 
the electrical slow wave and are necessary for coordinated 
peacemaking of GI contraction. 25 • 26 Kit-positive cells in the 
zebrafish are expected to be small and the myenteric plexus layer 
is expected to be thin when compared to mammalian models; 
detection of Kit-positive cells will require high sensitivity. 
The utility of each antigen retrieval solution is based on 
the ability of the solution to increase positive 
immunoreactivity, while maintaining low to moderate levels of 
nonspecific background staining. Optimal antigen retrieval 
solutions will restore positive immunostaining uniformly 
throughout the sample, and maintain adequate tissue integrity 
throughout the immunohistochemical analysis. Non-retrieved 
sample lacked immunostaining (figure 4), and were utilized as a 
base for comparison of retrieval methods. In non-retrieved 
samples (figure 4), the intensity of Kit-like reactivity is not 
distinguishable from the punctuate background staining. This 
lack of staining suggested possible,masking effect~ due to 
fixation artifacts, and led to the evaluation of several antigen 
retrieval techniques for enhancement of Kit-like 
immunoreactivity. 
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Kit-like immunoreactivity is optimized by citraconic acid 
(figure 5), citrate (figure 6), and Dako (figure 7) solutions. 
The Abeam (figure 8) solution mediated retrieval of only portions 
of tissue sections, but the immunoreactivity areas were robust. 
Protease K retrieval (figure 9) was ineffective and greatly 
damaged the tissue. 
Central 
Lacteal 
Deep 
Muscular Plexus Circular Smooth Muscle 
Myenteric Plexus 
Figure 2. 20X transverse section of the zebrafish Gl tract stained with 
hematoxylin and eosin. The myenteric plexus is highlighted in green 
and the deep muscular plexus is highlighted in blue; these two plexuses 
are predicted by this thesis to be sites of kit-like immunoreactivity. 
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Figure 3. 40X transverse section of the zebrafish Gl tract stained with 
hematoxylin and eosin. The myenteric plexus is highlighted in green 
and the deep muscular plexus is highlighted in blue; these two plexuses 
are predicted by this thesis to be sites of kit-like immunoreactivity. 
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Figure 4. Kit-like immunohistochemistry without 
antigen retrieval. Low (A. 20X) and high (B. 
40X) magnification in transverse sections is 
indistinguishable from background staining. 
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Figure 5. Ci1Iaconic acid re1rieval solution improves Kit-like 
immunohistochemistry. Kit-like immunoreactivity in 
transverse sections is observed in 2 distinct layers within the 
muscularis extema of the adult zebrafish CI tract Low (A, 
20X) and high (B~ 40X) map)lification fluorescent micrographs 
show that ci1Iaconic acid re1rieval solution enhances Kit-like 
antigenicity~ does not increase background staining, and 
maintains tissue motphology. Examples ofKit-like 
immunoreactivity within the myenteric and deep muscular 
plexuses are shown by the blue and red arrows respectively. 
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Figure 6. Citrate retrieval solution improves Kit-like 
immunohistochemis1Iy. Kit-like immunoreactivity in transverse 
sections is observed in 2 distinct layers within the muscularis 
extema of the adult zebrafish CI tract Low (A, 20X) and high 
(B, 40X) magnification fluorescent micrographs show that citrate 
retrieval solution enhances Kit-like antigenicity, increases 
background staining, and maintains tissue morphology_ 
Examples of Kit-like immunoreactivity within the myenteric and 
deep muscular plexuses are shown by the blue and red arrows 
respectively. 
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Figure 7. DAKO commercially available retrieval solution 
improves Kit-like immunohistochemistry. Kit-like 
immunoreactivity in transverse sections is observed in 2 distinct 
layers within the muscularis extema of the adult zebrafish CI 
tract Low (A, 20X) and high (B, 40X) map)1ification 
fluorescent micrographs show that DAKO retrieval solution 
enhances Kit-like antigenicity, slightly increases background 
stainin& and maintains tissue morphology. Examples ofKit-
like immunoreactivity within the myenteric and deep muscular 
plexuses are shown by the blue and red arrows respectively. 
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Figure 8. Abeam commercially available retrieval solution 
improves Kit-like immunohistochemistry. Kit-like 
immunoreactivity in transverse sections is observed in 2 poorly 
defined layers within the muscularis extema of the adult 
zebra.fish CI tract Low (A, 20X) and high (B .. 40X) 
magnification fluorescent micrographs show that Abeam 
retrieval solution enhances Kit-like antigenicity, significantly 
increases background staining, and slightly damages tissue 
mmphology. Examples of Kit-like immunoreactivity within the 
myenteric and deep muscular plexuses are shown by the blue and 
red arrows respectively. 
so 
Figure 9. Protease K. retrieval solution does not improve Kit-
like immunohistochemistry. Low (A, 20X) and high (B, 40X) 
magnification fluorescent micrographs show that Protease K. 
retrieval solution does not enhances Kit-like antigenicity, 
significantly increases background staining. and severely 
damages tissue motphology. 
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Several non-enzymatic antigen retrieval techniques were 
successful at retrieving Kit-like immunoreactivity to levels 
above background. Citraconic acid (figure 5) retrieved Kit-like 
immunoreactivity with the best signal to noise ratio, maintained 
tissue integrity, and resulted in consistent and uniform 
staining. Citrate (figure 6) and Dako (figure 7) solutions 
maintained tissue integrity well, induced immunoreactivity. 
However, the Dako solution (figure 7) had a slightly better 
signal to noise ratio then the citrate solution (figure 6) . The 
Abeam solution (figure 8) was able to mediate detectable Kit-like 
immunoreactivity; however, Abeam retrieved samples showed more 
tissue disruption and less uniform staining then other tested 
non-enzymatic retrieval solutions. 
In converse to the success of several non-enzyme mediated 
antigen retrieval solutions, enzymatically retrieved samples 
utilizing protease K (figure 9), resulted in ineffective 
unmasking of antigen. Protease K treated samples (figure 9) 
displayed enhanced background staining, without enhancing Kit-
like immunoreactivity; in addition, the treatment was very 
destructive to tissue integrity. Due to the deleterious effect 
on tissue integrity and lack of enhancement Kit-like signal to 
noise, protease K mediated enzymatic antigen retrieval is not 
recommended. 
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All of the assayed non-enzymatic methodo l ogies of Kit-like 
antigen retrieval were adequate to enhance Kit-like 
immunoreactivity above the l evel of background ; clearly , 
citraconic acid mediated retrieval (figure 5) was the most 
effective of all antigen retrieval techniques assayed . Dako 
(figure 7) and citrate (figure 6) solutions were roughly 
equivalent in their retrieval capabilities ; the Dako solution 
(figure 7) resulted in s l ightly greater enhancement of Kit - like 
immunoreactivity , while maintaining slightly lower levels of non-
specific background staining . The Abeam solution (figure 8) did 
mediated enhancement of Kit - like immunoreactivity , but often led 
to less uniform staining and greater tissue disruption than did 
citraconic acid(figure 5) , Dako (figure 7) , or citrate (figure 
6). Overall , protease K (figure 9) treatment had a net negative 
effect on Kit-like immunoreactivity , and t herefore i s not 
recommended . The overall results of this comparison study are 
summarized in table 2 . 
Table2. Effects ofVariousAntigen Retrieval Conditions on 
Kit-like Immunoreactivity 
CitraconicAcid Citrate Buffer 
1M BG TI u 1M BG TI u 1M 
+++ + +++ + ++ ++ 
Dako(S2369} Abeam (ab973} 
1M BG TI u 1M BG TI u 1M 
++ + ++ ++ ++ + + 
1M:: Relativeea1iJmdigaofia:llolmahiatotemU:.alreaclivity;-:~e, +:weaklypositiw, 
++: poaitMI, +++: lltftD8Iy poailiwe 
BG: Relative estimmoa ofllOIIIp8Ci6c badgroullllllbiJDg -: .egliP,Ie, +: 'IJieak, 
++: :moclerale, +++: abmlg 
TI: Relative eatiJUIIiuaoftiasueildfgritypolllrebieval; -: litOeonao clmmge, 
+: aligld dunage, ++: moclfnleclmmge, +++: 14Mftlcimmge or loa oftiasue 
U: Relative estima:1iaa ofllllifmoitym stmngpaUfD; -: plllduide, +:partial, 
++:moderidely~ +++: 'lllli.bm 
Proteinase K 
BG TI 
++ +++ 
Control 
BG TI 
u 
u 
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4. Discussion 
ICC identification most commonly relies on Kit 
immunohistochemistry, but the most reliable method is electron 
microscopy. 2 ' 24 Immunohistochemistry relies upon antibody-
dependent protein identification, which gives rise to the 
possibility of a non-ICC cell type expressing the Kit protein; 
hematopoietic and mast cells in mammalian tissues are known to 
express Kit. The available antibodies used for this study were 
developed for human antigens, which raises the possibility that 
zebrafish Kit orthologues are not specifically detected by these 
reagents. Thus, anatomical location and cell morphology must be 
taken into account when using Kit immunoreactivity to visualize 
ICC. The myenteric plexus is juxtaposed between the circular and 
longitudinal layers of the GI smooth muscle of the tunica 
muscularis. ICC within the myenteric plexus of the GI tract are 
of most interest; myenteric plexus ICC are closely associated 
with enteric neurons, have bipolar or stellate processes, and are 
arranged in a well organized network. 
The zebrafish has great potential as a model for GI 
dysmotility, ICC function, and drug discovery; therefore, 
optimization of Kit-like immunohistochemical detection within the 
zebrafish GI tract is desirable. Zebrafish are optically 
transparent as larvae, and have fully functional GI tracts by 
five days post fertilization. It is possible to use 
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immunohistochemistry to visualize GI tract cells in the whole 
larvae at a fully functional developmental stage, and quantify GI 
contractions in living fish. Larvae directly absorb small drug 
molecules, which makes the zebrafish attractive to drug 
developers for the combinatorial library screening. It has 
recently been shown in adult tissue and whole mount of larval and 
adult tissue that Kit-like immunoreactivity is present in the GI 
system of the zebrafish. 27 Expression of mRNA ~or the kit 
receptors and kit ligands has be identified in the zebrafish GI 
tract. 27 Antigen retrieval is necessary for identification of 
Kit-positive cells in transverse sections of GI tissues using the 
anti-Kit polyclonal antibody, ab16832 (abeam) in 
paraformaldehyde-fixed, paraffin embedded tissues. Citraconic 
acid antigen retrieval solution resulted in the most intense and 
uniform immunoreactivity of the assayed solutions. Additionally, 
citraconic acid mediated antigen retrieval did not significantly 
compromise tissue integrity, nor did it raise non-specific 
background staining above acceptable levels. 
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Kit-Like Immunoreactivity in the Zebrafish 
Gastrointestinal Tract Reveals Putative Icct 
A. Rich,t• S.A. Leddon,l S.L. Hess/ S.J. Gibbons,2 S. Miller,2 X. Xu,2 and G. Farrugai2 
Gastrointestinal (GI) motility results from the coordinated actions of enteric neurons, interstitial cells of 
Cajal (ICC), and smooth muscle cells. The Gl tract of the zebrafish has a cellular anatomy that is essentially 
similar to humans. Although enteric nerves and smooth muscle cells have been described, it is unknown if 
ICC are present in the zebrafish. Immunohistochemistry and PCR were used determine expression for the 
zebrafish Kit orthologue in the zebrafish gastrointestinal tract. Cells displaying Kit-like immunoreactivity 
were identified in the muscular layers of the adult zebrafish gastrointestinal tract. Two layers of Kit· 
positive cells were identified, one with multipolar cells located between the longitudinal and circular 
smooth muscle layers and one with simple bipolar cells located deep in the circular muscle layer. Primers 
specifically designed to amplify mRNA coding for two zebrafish kit genes, kita and kitb, and two kit ligands, 
kitla and kitlb, amplified the expected transcript from total RNA isolated from zebrafish GI tissues. The 
Sparse mutant, a kita null mutant, showed reduced contraction frequency and increased size of the GI tract 
indicating a functional role for kita. These data establish the presence of a cellular network with Kit-like 
immunoreactivity in the myenteric plexus region of the zebrafish GI tract, adjacent to enteric neurons. 
Expression of kita and kitb, and the ligands kitla and kitlb, were verified in the adult GI tract. The 
anatomical arrangement of the Kit·pQsitive cells strongly suggests that they are ICC. Developmental Dy-
namics 236:903-911, 2007. c 2007 Wiley-Liss, Inc. 
Key words: Kit immunohistochemistry; zebrafish; interstitial cells of Cajal (ICC); gastrointestinal tract motility 
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INTRODUCTION 
Gastrointestinal (GI) motility is pri-
marily mediated by complex interac-
tions between enteric neurons, inter-
stitial cells of Cajal (ICC), and smooth 
muscle cells. These cell types have 
been identified and characterized in 
many vertebrate model systems in· 
eluding the mouse, guinea pig, rat, 
dog, chick, and human (Faussone-Pel-
legrini and Thuneberg, 1999; Komuro, 
1999; Sanders et al., 1999; Young, 
1999). It is now widely understood 
that ICC play a vital role in regulating 
GI motility. ICC generate a pacing sig· 
nal that drives smooth muscle, medi-
ates neuronal input to smooth muscle, 
and establishes a smooth muscle 
membrane potential gradient across 
the thickness of the circular smooth 
muscle layer (Huizinga et al., 1995; 
Farrugia et al., 2003; Strege et al., 
2003; Ward et al., 2004; Sanders et al., 
2006). Disturbances in ICC distribu-
tion have been correlated with GI dye-
motilities in animal model systems, 
and in humans (He et al., 2000, 2001; 
Huizinga et al., 2001; Lyford et al., 
2002; Sanders et al., 2006). The ze-
brafish is a well-established model 
system for studies on development, 
and is an important model system for 
human disease (Dodd et al., 2000; 
Goldsmith, 2004). Zebrafish larvae 
are transparent, which allows direct 
observation of organ function in the 
intact organism. The GI tract is func-
tional and is apparently fully formed 
at 5 days post fertilization (dpf). Mus-
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cular contractions can be directly ob-
served in unperturbed intact larvae. 
Therefore, the functional role played 
by enteric neurons, ICC, and smooth 
muscle can be examined within an in-
tact, living network unllke other 
model organisms where direct obser-
vation of GI organogenesis and GI 
function is not possible. 
Establishing a zebrafish-b~sed 
model system for GI motility requires 
identification of enteric neurons, ICC, 
and smooth muscle cells in the GI 
tract, as well as the characterization 
of function at developmental time 
points. Smooth muscle cells are evi-
dent at 50 hr post fertilization (hpf) 
and the longitudinal and circular 
muscle layers are well established by 
96 hpf(Wallace eta!., 2005a). Enteric 
neurons are observed by 72 hpf, com-
pletely populate the GI tract by 96 
hpf, and increase in nu~ber to 120 hpf 
(Kelsh and Eisen, 2000; Shepherd et 
a!., 2004). Therefore, both enteric neu-
rons and smooth muscle cells appear 
well established by 5 dpf, coinciding 
with observations of spontaneous GI 
contractions and feeding (Holmberg et 
a!., 2004). For comparison, ICC in the 
mouse model begin to develop at em-
bryonic day 15, irregular and sponta-
neous electrical rhythmicity develops 
by embryonic day 18, and adult-like 
slow waves were recorded 9 days after 
birth (Ward eta!., 1997; Beckett eta!., 
2006) ICC play a vital role in develop-
ing coordinated GI contractions that 
function to mix and propel the luminal 
contents of the gut (Sanders et a!., 
1999). However, the presence of ICC 
in zebrafish fish has not been reported 
previously. 
Identification of ICC in the GI tract 
may be accomplished using Kit as a 
selective and specific marker (H uiz-
inga et al., 1995; Burns et a!., 1997; 
Kluppel et a!., 1998; Faussone-Pelle-
grini and Thuneberg, 1999; Komuro, 
1999; He et a!., 2000, 2001; Lyford et 
a!., 2002) The proto-oncogene c-kit is 
expressed by ICC located within the 
tunica muscularis of the GI tract of 
mice, guinea pigs, rats, dogs, and hu-
mans. Antibodies specific for this pro· 
tein label ICC within GI tissues in 
several species, including humans, 
and have been widely utilized to both 
determine ICC cellular morphology, 
and to characterize sub-populations of 
ICC located in distinct layers of the 
muscular wall of the GI tract (Ward 
and Sanders, 1992; Ward eta!., 1994; 
Burns et al., 1997; Ozaki et a!., 2004; 
Komuro, 1999). Several classes ofiCC 
have been identified. Each class is dis-
tinguished according to cellular mor-
phology, anatomical location, and 
function (Faussone-Pellegrini and 
Thuneberg, 1999; Komuro, 1999; 
Sanders et a!., 1999). The myenteric 
plexus region, located between the cir-
cular and longitudinal muscle layers, 
exhibits the highest ICC density and 
the myenteric ICC network is contin-
uous throughout the mammalian GI 
tract (Burns et a!., 1997; Hirst and 
Edwards, 2004). A second network of 
ICC, termed deep muscular plexus 
ICC, is located between the thin in-
nermost and thicker outer layer of cir-
cular muscle of the mammalian small 
intestine (Burns et a!., 1997; Komuro, 
1999). Deep muscular plexus ICC are 
typically bipolar and are oriented in 
parallel with circular smooth muscle, 
and receive excitatory and inhibitory 
synaptic input from the enteric ner-
vous system (Wang eta!., 1999; Wang 
et al., 2003; Iino et a!., 2004). 
Two orthologs of the mammalian c-
Kit receptor tyrosine kinase have been 
identified in the zebrafish, kita and 
kitb (Parichy et a!., 1999; Mellgren 
and Johnson, 2005). The zebrafish 
Sparse mutant is characterized by a 
deficit in stripe melanocytes resulting 
from a null allele of kita (Parichy et 
a!., 1999). Zebrafish kita plays an es-
sential role for the migration and sur-
vival of embryonic melanocytes, but 
the role and/or expression of kita and 
kitb in the Gl tract have not been re-
ported. Because c-Kit signaling is es-
sential for the normal development of 
ICC and rhythmic activity in the 
mouse GI tract, identification of the 
kita and kith protein in the zebrafish 
GI tract as well as functional motility 
differences in the Sparse mutant 
would support the presence of ze-
brafish ICC (Ward eta!., 1994; Huiz-
inga et a!., 1995; Kluppel et a!., 1998). 
The objective of this study was to de-
termine the presence or absence of 
Kit-like immunoreactivity within the 
m~scular outer layers of the zebrafish 
GI tract, consistent with the presence 
ofiCC. 
RESULTS 
'Kit expression in the zebrafish Gl 
tract was identified using a rabbit 
polyclonal antibody specifically de-
signed to recognize C terminal amino 
acids 961-976 of human c-Kit. A con-
tinuous and extensive network of cells 
displaying Kit-like immunoreactivity 
was observed within the muscular lay-
ers of paraformaldehyde-fixed adult 
zebrafish GI tract (Fig. 1). Two dis-
tinct populations of cells were ob-
served in separate layers of whole 
mount tissue. One layer displayed 
elongated cell bodies with multiple 
branching processes forming a loose 
but regular network pattern (Fig. 1B), 
and a second layer was comprised of 
bipolar or simple bifurcating cells lo-
cated deeper within the circular mus-
cle layer (Fig. 1C). Images shown are 
taken from mid-intestinal segments, 
as classified by Wallace et a!. (2005a). 
Substantial differences in distribution 
of Kit-positive cells in each segment 
were not observed. 
Spontaneous contractions of the ze-
brafish GI tract begin at 4 dpf, coin-
ciding with the development of enteric 
neurons, but the possibility for ICC 
contributing to the development of 
rhythmic contractions has not been 
explored (Kelsh and Eisen, 2000; 
Shepherd eta!., 2004; Wallace eta!., 
2005b). Kit expression was identified 
in the GI tract of paraformaldehyde-
fixed zebrafish larvae. The G I tract 
was carefully dissected from larvae 
prior to immunostaining to maximize 
antibody penetration of intact tissues. 
Single confocal sections taken midway 
through the digestive tube are shown 
for 7,11, and 20 dpflarvae (Fig. 1D-F, 
respectively). Cells displaying Kit-like 
immunoreactivity were observed in 
the outer layer of the tunica muscu-
laris, indicated by arrowheads. Kit ex-
pression appeared to increase from 7 
to 1~ dpf, and it was possible to iden-
tify an apparent network of Kit-posi-
tive cells at 20 dpf. Kit-ljke immuno-
reactivity was not observed prior to 7 
dpf (data not shown). It was not pos-
sible to separate the mucosa from the 
tunica muscularis in adult or larvae 
GI tissues, which contributed to high 
background staining and prevented 
complete confocal stack recoi,IBtruc-
tions of the full-thickness digestive 
tract in larvae. The ACK2 rat mono-
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Fig. 1. Anti-Kit rabbrt polyclonal antibody identifies putative ICC networks in the adult zebrafish 
Gl tract. Full thickness confocal stack reconstruction of an adult zebrafish Gl whole mount 
preparation immunostained using rabbit anti-Kit polyclonal antibody (A). Total thickness of recon-
structed stack ~20 .,.m. Reconstruction of a partial thickness stack (- 8-.,.m-thick) shows a 
kit-positive network in the myenteric plexus region with stellate-shaped, highly branching cells (B). 
A second distinct network of slender bipolar cells oriented parallel to the circular smooth muscle 
cells was located closer to the submucosaJ border and is shown in a partial stack reconstruction 
of a 6-.,.m-thick region (C). Kit-like immunoreactivity was observed in the Gl tract of zebrafish larvae 
beginning at 7 dpf. Single confocal sections approximately 0.6-.,.m-thick of mid-saggital sections 
from the posterior end of the larvae Gl tract show branching cells with slender processes in the 
tunica muscularis {0 , arrows). Background staining of the mucosal layer prevented full-thickness 
stack reconstruction. The density of Kit-positive cells was increased at 11 dpf (E), and a network 
of Kit-positive cells was observed at 20 dpf (F) . Scale bars = 20 .,.m. 
clonal antibody that has been widely 
used to identify mouse ICC also spe-
cifically identified cellular networks in 
acetone-fixed adult and larvae ze-
brafish GI tissues (data not shown). 
Two types of l{jt-positive cells are 
observed at high magnification: one 
branching cell with prominent nuclei 
(black arrow) and thinner bipolar cells 
(Fig. 2A). The anatomical position of 
these cells was determined in trans-
verse sections of adult zebrafish GI 
tissues. Hematoxilyn and eosin 
stained transverse sections show that 
the outer longitudinal and inner circu-
lar smooth muscle layers are approxi-
mately 2 and 4-5 cell layers thick, 
respectively (Fig. 2B). l{jt-like immu-
noreactivity was consistently ob-
served in two distinct layers of cells in 
transverse sections of adult GI tissues 
(Fig. 2C). The outer layer of cells with 
l{jt-like immunoreactivity appeared 
more dense and continuous, and a sec-
ond thinner layer of l{jt-positive cells 
was observed closer to the lumen . The 
inner layer was discontinuous and ori-
ented in parallel with the circular 
smooth muscle cells. Both layers of 
l{jt-positive cells were observed in an-
terior, mid, and posterior intestinal 
segments. The anatomical position of 
l{jt-positive cells was also determined 
using transverse sections of zebra fish 
larvae. A single continuous layer of 
l{jt-positive cells within the tunica 
muscularis of the GI tract was ob-
served in 13 dpf larvae (Fig. 2D). 
The relative anatomical positions of 
l{jt-positive cells, enteric neurons, 
and smooth muscle cells in the ze-
brafish GI tract was examined further 
for comparison with established mam-
malian model systems. A pan-neuro-
nal antibody, anti HuC/D, was used to 
identify cell bodies, and anti-acety-
lated a-tubulin antibody was used to 
identify neural processes. Composite 
images resulting from dual labeling 
experiments with whole mounted tis-
sue show that cells displaying l{jt-like 
immunoreactivity are in the same 
area as neuronal cell processes, la-
beled with acetylated a-tubulin anti-
body (Fig. 3A). Composite images of 
transverse sections show l{jt-positive 
cells and neural cell processes are lo-
cated in the myenteric plexus region 
(Fig. 3B). Similarly, dual labeling 
with anti Hu C/D and anti-l{jt anti-
body shows neural cell bodies located 
near l{jt-positive cells in whole 
mounted tissues, and in the myenteric 
plexus region in transverse sections 
(Fig. 3C and D ). Enteric nerves were 
only occasionally observed to extend 
deep into the circular muscle layer 
near the thin inner layer of l{jt-posi-
tive cells (data not shown). Dual label-
ing with anti-SM22 antibody to detect 
smooth muscle cells and anti-c-Kit an-
tibody identified longitudinal and cir-
cular smooth muscle layers, and l{jt-
positive cells located between the 
layers in the whole mounted tissue 
(Fig. 3E). Smooth muscle cells were 
identified using an anti-Desmin anti-
body in transverse sections. Desmin is 
an intermediate cytoskeleton filament 
protein expressed by GI smooth mus-
cles. Composite images of transverse 
sections dual ' labeled with anti-
Desmin and anti-Kit antibody show 
one dense layer of l{jt-positive cells 
positioned between the longitudinal 
and circular muscle layers and a sec-
ond thin layer of l{jt-positive cells 
near the innermost circular smooth 
muscle cells (arrowhead, Fig. 3F). 
Expression of the zebrafish or-
thologs of mammalian c-l{jt was veri-
fied by determining mRNA expression 
for the kita and kitb genes within GI 
tissues. Reverse transcriptase PCR 
was performed on eDNA prepared 
from total RNA isolated from adult 
zebrafish GI tissues. The presence of 
mRNA for two known orthologs of the 
c-Kit receptor, kita and kitb , as well as 
orthologues of c-Kit ligand, kitla and 
kitlb, were determined using specific 
primer sets for each gene, and for 
[\-actin as a positive control (see Table 
1). Primers were intron-spanning to 
rule out the possibility of genomic con-
tamination. Products of the expected 
size for kita, kitb, kit/a , and kitlb were 
amplified (Fig. 4). The identity of the 
bands was confirmed by sequencing. 
These data show for the first time the 
presence ofmRNA encoding kita, kitb, 
and the ligands for these receptors, 
kit/a and kitlb , in the zebrafish GI 
tract. 
Development of ICC requires func-
tional c-l{jt signaling during embryo-
genesis in the mouse model, and also to 
62 
906 RICH ET AL. 
mamtain ICC in adults (Maeda et al., 
1992; Torihashi et al., 1995; Beckett et 
al. , 2006). We examined homozygous 
Sparse mutants spab5 (ZDB-FISH-
980202-4 7) for functional differences in 
GI motility and for differences in ap-
pearance of the GI tract to determine a 
role for the kita gene. Contraction fre-
quency was reduced in Sparse mutants 
compared to wild-type 7 dpf larvae. 
Contraction frequency averaged 0.59 :':: 
0.05 (mean :':: standard error, n = 20) 
contractions per minute in wild-type 
larvae, and 0.33 :':: 0.03 (mean :':: stan-
dard error, n = 23, P s 0.05) contrac-
tions per minute in Sparse mutants 
(Fig. 5). Inactivation of c-Kit by injec-
tion of the neutralizing antibody ACK2 
in the mouse resulted in distension of 
the stomach, small intestine, and colon, 
and, therefore, the size of the GI tract in 
Fig. 2. Cells with Kit-like immunoreactivity form 
a dense network in the myenteric plexus region, 
and a second network close to the circular 
smooth muscle-submucosal border. High mag-
nification of Kit-positive cells reveals individual 
stellate-shaped cells (white) in a full thickness 
stack (A). Circular and longitudinal muscle lay-
ers of the adult Gl tract are clearly observed in 
H&E stained transverse sections (B). Kit-posi-
tive cells are found in the myenteric plexus re-
gion, and a thin layer of Kit-positive cells is 
located near the circular smooth muscle-sub-
mucosal border (C). A single layer of Kit-posi-
tive cells was observed in the tunica muscularis 
of transverse sections of zebrafish larvae (white 
arrow) (D). Scale bars ~ 20 IJ.m. 
Fig. 3. Dual staining shows the relative position 
of Kit-positive cells and enteric neurons or 
smooth muscles. Cell morphology is shown in 
whole mounted adult tissues (left), and the po-
sition and orientation of each layer is shown in 
transverse sections (right). Composite images 
using anti-Kit and the anti-tubulin antibodies 
show Kit -positive cells (A, red) near neuronal 
cell processes (green , A). Composite images 
using the pan-neuronal antibody anti-Hu 
(green) show cells with Kit- like immunoreactiv-
ity (red) near neural cell bodies (C). Transverse 
sections show 2 separate layers of kit-positive 
cells. Kit-positive cells and neural processes (B) 
or neural cell bodies (D) were observed in the 
myenteric plexus region. Dual staining with an-
ti-Kit and anti-SM22 or anti-Desmin antibodies 
show the relative positions of Kit-positive and 
smooth muscles. Dual staining in whole mount 
tissues shows outer longitudinal and inner cir-
cular smooth muscles (green, E) and cells with 
Kit-like immunoreactivity (red). Composite im-
ages of transverse sections clearly show the 
layers of longitudinal and smooth muscle sep-
arated by Kit-positive cells, and a second layer 
of kit-positive cells near the innermost border of 
circular smooth muscle. Sale bars = 20 ~m. 
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TABLE 1- Oligonucleotide Primer Sequences 
Target Sequence Expected size (bp) 
ltita (AF 153446) F: GTT ATC CCA CTC CTC AGA TCA AGT 564 
R: TCA CAG CTA CAG TCATCA CAG TGT 
ltitb (DQ072166) F: GGG AGG AAT CAC CAT CAG AA 234 
R: CTC AGG TGG AAA TCGTGG TT 
ltital (AY929068) F:CACAGTTGCTGCCTATTCCA 580 
R:GGTGAGGAGCCACCTGAGAT 
Kitbl (A Y929069) F: GGC TGC ATT TGA ACC TGT ATC C 542 
R: GTG TCT GCA CAC CCTAAA GAA TCC 
ll actin (BC067566) F: GAT ACG GAT CCA GAC ATC AGG GTG TCA TGG 580 
TTGGTA 
R: GAT ACA AGC TTA TAGCAG AGC TTC TCC TTG 
600 bp 
--400 bp 
--234 bp 
--
ATG 
Fig. 4. AT -PCR amplifies the zebrafish Kit re-
ceptor tyrosine kinase kita and kitb , and Steel 
factor, kit/a and kitlb , from isolated adult Gl 
tract . Amplification products are shown for 
primer sets designed for each gene (Table 1 ), 
and for ~-actin. Products of correct size for 
each primer set were observed and confirmed 
by sequencing. 
Sparse mutants was compared to 
wildOtype larvae (Maeda et al., 1992; 
Torihashi et al., 1999). Sparse and wild-
type larvae were incubated for 1 hr in 
media containing FITC-labeled dex-
tran, anesthetized, and washed. The lu-
men of the GI tract was observed using 
fluorescence microscopy. The cross-sec-
tional area of the lumen was outlined 
from fluorescent images and measured 
using Image Pro Plus software (Media 
Cybernetics, version 5.0). The size of the 
GI tract in 7 dpf Sparse mutants was 
larger compared to 7 dpfwild-type lar-
vae, 12,331 :±: 467 fLm 2 and 14,985 :±: 
483 fLm2 , respectively (mean :±: stan-
dard error, n = 20 wild-type, 12 Sparse , 
P s 0.05). Adult Sparse zebrafish con-
sistently exhibited a distended GI tract, 
which was most apparent in the intes-
tinal bulb (data not shown). Cells dis-
playing Kit-like immunoreactivity were 
observed in Sparse mutant larvae and 
in adult GI tissues, with a similar den-
sity as wild-type zebrafish (data not 
shown). 
DISCUSSION 
Resul ts presen ted here show th at an-
ti-Kit antibodies identify a network of 
cells located between the circular and 
longitudinal muscle layers of the adult 
zebrafi sh GI tract and a separate, sec-
ond group of cells in a region analo-
gous to the boundary between the in-
ner and outer circular muscle in the 
mouse. Expression ofmRNA encoding 
for the two zebrafish orthologues of 
mammalian Kit, kita, and kitb, as well 
as two orthologues for mammalian Kit 
ligand, kitla and kitlb , was confirmed 
in adult zebrafish GI tissues. The Kit-
posit ive cells were distributed in the 
myenteric plexus region near enteric 
neurons. A reduction in contraction 
frequency and an increase in size of 
the GI tract were observed in 7 dpf 
Sparse mutant larvae, which exhibit a 
null kita allele. These data are consis-
tent with expression of zebrafish or-
thologs to the mammalian c-Kit recep-
tor tyrosine kinase, kita and kitb , in 
the zebrafish GI tract. Furthermore, 
the data strongly indicate the pres-
ence of ICC in the zebrafish GI tract, 
which are distributed similarly to 
mammalian ICC, thus establishing 
the zebrafish as a suitable model sys-
tem for mammalian GI motility. 
Expression of kita and kitb was not 
detected previously in zebra fi sh lar-
vae at 4 dpfusing in situ hybridization 
techniques (Parichy et al., 1999; Mell-
gren and Johnson, 2005). Our data 
confirm this result. Kit-like immuno-
reactivity was not detected in 5-dpf 
larvae, and was first detected at 7 dpf. 
It is likely that expression of kita and 
kitb occurs developmentally later then 
4 dpf, or that mRNA levels in the 4-dpf 
GI tract occur at very low and not 
detectable levels by in situ hybridiza-
tion techniques. Functional data show 
that spontaneous contractions of the 
GI tract that develop near 4 dpf are 
poorly organized (Holmberg et al., 
2004). Coordinated contractions, 
which are better organized and con-
tribute to propulsive motility move-
ments, develop gradually between 5 
and 7 dpf, consistent with the time 
course of appearance of Kit immuno-
reactivity (personal observation). The 
role of ICC on intestinal transit has 
been well characterized in the mouse 
model and mutant mice lacking ICC 
exhibit spontaneous but poorly orga-
nized contractions and delayed intes-
tinal transit (Torihashi et al., 1995, 
1997; Ward et al., 1995). The poorly 
organized contractions in early ze-
brafish development are, therefore, 
similar to the ICC-deficient mutant 
mouse model. The morphological data 
from these studies are consistent with 
the presence of myenteric ICC and 
deep muscular plexus ICC, similar to 
the mouse small intestine. However, 
no obvious differences were observed 
in the distribution of Kit-positive cells 
in anterior, mid, or posterior regions 
of the zebrafish GI tract, whereas in 
the mouse model deep muscular 
plexus ICC distribution differs region-
ally along the GI tract. The functional 
role of Kit-positive cells in the ze-
brafish GI tract, as well as the rela-
tionship between Kit-positive cells 
and enteric neurons, remains to be ex-
plored. 
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The physiological role of kita and 
kitb in the zebrafish GI tract is un-
known. Parichy et al. did not observe 
motility defects in kita null mutants 
(Sparse), and homozygous adults ap-
peared normal (Parichy et al., 1999). 
However, motility patterns are com-
plex, and quantification of spontane-
ous contractions in zebrafish larvae is 
notoriously difficult. Further, erratic 
spontaneous contractions of GI 
smooth muscles do not require ICC in 
the mouse model. Data reported here 
suggest that early spontaneous rhyth-
mic contractions observed in zebrafish 
larvae before 7 dpf also do not require 
ICC, because Kit-positive cells were 
not observed prior to 7 dpf. Therefore, 
overt GI motility deficits are not pre-
dicted for the Sparse mutant during 
early development and would not be 
observed. A role for kita in ICC devel-
opment is indicated by data from 
Sparse mutants showing a reduced 
frequency of spontaneous GI contrac-
tions in 7-dpflarvae. Further, the in-
creased surface area ofthe GI tract in 
Sparse mutants is highly similar to 
observations of an expanded small in-
testine in the W/Wv mutant mouse 
(Maeda et al., 1992; Torihashi et al., 
1995). Complete c-Kit inactivation 
mutants or the absence of Kit ligand is 
lethal for the mouse model but ho-
mozygous Sparse mutants survive to 
adulthood. This raises the possibility 
for a different physiological function 
for mammalian Kit and zebrafish kita. 
The recent discovery of a second Kit 
orthologue in the zebrafish, kitb, pro-
vides the possibility that kitb may be 
sufficient to support partial or com-
plete ICC development and survival in 
the zebrafish GI tract (Mellgren and 
Johnson, 2005). Survival of homozy-
gous kita null mutants suggests that 
kitb at least partially supports ICC 
development. Kit-like immunoreactiv-
ity was also observed in Sparse larvae 
and adult GI tissues, indicating that 
kitb contributes to ICC development 
and maintenance. Elucidating the 
specific roles for the zebrafish receptor 
tyr9sine kinase kita and kith during 
ICC development in the zebrafish, and 
examining whether kita and kitb are 
co-orthologous for human c-Kit will 
contribute to the understanding of 
ICC development during pathophysio-
logical conditions that contribute to 
GI dysmotility in the clinical setting. 
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Ag. 5. The pigment pattern mutation Sparse, a k~a null mutant, has decreased spontaneous Gl 
contractions and an Increased size of the Gl tract. Optically transparent zebrafish larvae (l dpt) 
were videotaped and contraction frequency was 0.59 :t 0.05 contractions/minute (mean :t SE, n = 
20) in wild type, and 0.33 :t 0.03 contractlon~mlnute (P < 0.05, n = 23) in homozygous Sparse 
mutant larvae. Cross-sectional area of the Gl tract was measured in single frames for each 
experiment. Cross-sectional area was less for wild-type, 12,331 :t 467, compared to the Sparse 
mutant larvae, 14,985 ± 483 (P < 0.05). 
ICC are the primary cell type that 
expresses c-Kit in the GI tract but 
mast cells are also labeled by anti-Kit 
antibody. The two cell types are easily 
distinguished because mast cells are 
round and granular in appearance but 
typical ICC display long, slender pro-
cesses and an oval body (Faussone-
Pellegrini and Thuneberg, 1999; 
Komuro, 1999). In the present study of 
the zebrafish GI tract, the cellular 
morphology of cells displaying Kit-like 
immunoreactivity showed multiple 
branching processes, or were slender 
and bipolar, and round cells were 
never observed. Definitive confirma-
tion of these cells as ICC may require 
electron microscopy to examine their 
ultra structure to determine if they 
posses features associated with mam-
malian ICC, such as a high density of 
mitochondria and intermediate fila-
ments, an absence of thick filaments, 
gap junction contacts with smooth 
muscle cells, and surface caveolae 
(Komuro, 1999). Characterization of 
the association between enteric neu-
rons and ICC will contribute to deter-
mining the functional role and classi-
fication of ICC in the zebrafish. 
The GI tract of the zebrafish lacks a 
stomach, and presents as a folded tube 
in the adult. The anterior segment, or 
intestinal bulb, exhibits the largest lu-
men and may function as a reservoir 
and mixing chamber, similar to a 
stomach. The anterior, mid, and pos-
terior portions roughly approximate 
the small and large intestine with re-
spect to absorptive function (Wallace 
et al., 2005a). Direct observation of 
muscular contractions in intact larvae 
show that contractions in the anterior 
segment are more frequent and more 
random when compared to mid and 
posterior segments where less fre-
quent but more ordered anterograde 
propagations appear. It will be inter-
esting to determine the role for enteric 
neurons and ICC in these distinctly 
different motility patterns. Although 
the development of contraction fre-
quency has been reported previously, 
functional studies, such as assessing 
transit through the GI tract, are lack-
ing (Holmberg et al., 2004). 
In summary, the results in this 
study show Kit-like immunoreactivity 
in the tunica muscularis of the ze-
brafish GI tract and provide func-
tional evidence for the role of kita in 
GI motility. Kit-positive cells in the 
zebrafish appear to correspond to my-
enteric ICC and deep muscular plexus 
ICC, based on cellular morphology 
and distribution. Expression of 
mRNA encoding kita, kitb, kitla, and 
kitlb was demonstrated in the ze-
brafish GI tract using PCR analysis. 
Mutants lacking functional kita 
showed a decreased contraction fre-
quency compared to wild-type ze-
brafish. Taken together, these data 
are consistent with the presence of 
ICC in th,ll zebrafish 'GI tract, and 
suggest that the zebrafish may be a 
suitable model system for human GI 
physiology. More work will be re-
quired to determine if Kit-positive 
cells in the zebrafish GI tract initiate 
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spontaneous, rhythmic contractions, 
transmit electrical activity along the 
long axis of the GI tract, and coordi-
nate enteric neurotransmission sim-
ilar to mouse ICC. 
EXPERIMENTAL 
PROCEDURES 
Aquaculture 
Wild-type and Sparse mutant ze-
brafish (ZFIN ID 960809-7 and 
980202-7) were obtained from the Ze-
brafish international resource center 
and maintained according to standard 
guidelines'in accordance with IACUC 
guidelines (Westerfield, 1993). Wild-
type long-finned golds (Scientific 
Hatcheries, Huntington Beach, CA) 
were also used for some preliminary 
experiments and no differences in im-
munohistochemical staining were ob-
served when comparing strains (data 
not shown). Fish were maintained at 
28°C in system water comprised of 
deionized water containing 240 mg/L 
Instant Ocean salts and 75 mg/L 
NaHC03 with 20% system water 
change each day (pH was adjusted 
to"' 7.2, conductivity ... 450 PPM). Ze-
brafish were fed 3 times daily, alter-
nating Cyclopeeze (Argent, Redmond, 
W A) with live brine shrimp, and main-
tained on a 14-hr/10-hr light/dark cy-
cle. Crosses were performed in the 
morning, and embryos were main-
tained in embryo medium in 400-ml 
beakers kept in 'a water bath set to 
28•c. Larvae were fed hatchfry encap-
sulation, grade 0, beginning at 7 dpf, 
and live brine shrimp after 11 dpf(Ar-
gent, Redmond, WA). 
Immunohistochemistry 
Adult and larvae zebrafish were anes-
thetized in system water containing 
MS222 (3-aminobenzioc acid ethyl es-
ter, Sigma Chemical Co., St Louis, 
MO) and sacrificed for immunohisto-
chemistry. Intact larvae and freshly 
dissected adult GI tissues were fixed 
in freshly prepared 4% paraformalde-
hyde in phosphate buffered saline 
(Fisher) with pH adjusted between 7.3 
and 7.4 for a minimum of2 hr, but not 
longer than overnight. Immunostain-
ing using the ACK2 antibody requires 
acetone fixation, and for these experi-
ments larvae and tissues were fixed 
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for 15 min in ice-cold acetone. Fixed 
tissues were washed 4 times in PBS 
containing 0.02% sodium azide. Lar-
vae were carefully dissected such that 
the GI tract was separated from the 
body so that the head remained at-
tached to the GI tract. Although time-
consuming, removing the GI tract in 
this manner allowed direct access for 
antibody-antigen binding, producing 
consistent immunostaining. Nonspe-
cific binding of primary antibody to 
tissues was minimized by incubation 
for at least 1 hr at 4 •c in blocking 
solution comprised of 10% normal 
donkey serum (NDS, Chemicon) and 
phosphate buffered saline containing 
0.02% sodium azide, 0.1% Triton-X-
100, and 0.05% -Tween 20 (PBS-TT). 
Primary antibodies were diluted in 
PBS-TT containing 5% normal donkey 
serum and were applied for 24-48 hr 
at 4•c on an orbital platform. After 
washing 4 times in PBS-TT, tissues 
were incubated with appropriate sec-
ondary antibody conjugated to a fluo-
rescent marker and diluted in PBS-TT 
containing 2.5% normal donkey serum 
for 24 hr at 4°C on an orbital platform. 
Nonspecific immunoreactivity was as-
sessed by immunostaining tissues or 
larvae in an identical manner but 
with the primary antibody omitted. 
The optimal concentration for each 
primary and secondary antibody was 
determined using serial dilutions. An-
tibodies were applied simultaneously 
during dual labeling experiments, fol-
lowed by a PBS-TT wash and the si-
multaneous application of two appro-
priate secondary antibodies. Tissues 
were washed with PBS-TT and 
mounted on glass slides using Slow 
Fade medium <Invitrogen). 
Paraffin-embedded sectioned 
tissues. 
Adult fish were anesthetized in MS 
222, decapitated posterior to the gills, 
tails were removed to aid fixative pen-
etration and were immersed in freshly 
prepared 4% paraformaldehyde over-
night at 4•c on an orbital platform. 
The GI tract was subsequently dis-
sected and washed with PBS followed 
by 70% ethanol. Tissues were dehy-
drated and paraffin embedded using a 
Tissue-Tek VIP E150 processor with 
1-hr infiltration steps at 70% (1 step), 
95% (2 steps), 100% (2 steps) ethanol, 
followed by xylene (3 steps) and par-
affin infiltration (30 min, 4 steps) com-
prising a 12-hr schedule. GI tissues 
were sectioned into anterior, mid, and 
posterior portions and embedded in a 
paraffin block oriented for transverse 
sections. One piece of paraformalde-
hyde-fixed mouse GI tract (small in-
testine) was included in each block to 
serve as a positive control for immu-
nostaining. Paraffin blocks were 
stored at 4•c until sectioning. Speci-
men blocks were trimmed, soaked in 
ice water for 30 min, and sectioned at 
either 4 or 8 ...,m using a Reichart-
Jung microtome. Sections were placed 
on slides (Superfrost plus, Fischer), 
baked 'at 56°C for 1 hr, and stored at 
-2o•c until de-paraffinization. 
Slides with sectioned tissues were 
placed on a 56°C warming tray for 5 
min, and then a xylene bath for de-
paraffinization (2 steps, 5 min). Tissue 
sections for hematoxylin and eosin 
staining were rehydrated using a 
graded alcohol series; 100% (2 steps, 3 
min), 95% (2 steps, 3 min), followed by 
diH20 (1 step, 10 min). Tissue sec-
tions used for immunohistochemistry 
were similarly rehydrated followed by 
PBS-TT (1 step, 10 min). Preliminary 
immunostaining experiments using 
anti-Kit antibody resulted in a weak 
signal, and therefore antigen retrieval 
techniques were utilized to enhance 
specific immunoreactivity. Slides were 
immersed in antigen retrieval solu-
tion (Abeam) at 1oo•c for 20 min., al-
lowed to cool to room temperature in 
the same solution, and rinsed in PBS-
TT. Immunostaining was performed 
at room temperature. Tissue sections 
were incubated in blocking solution (1 
hr), primary antibody solution (1 hr), 
and secondary antibody solution (1 
hr). Optimal dilutions were deter-
mined for each primary and secondary 
antibody. Wash steps using PBS-TT 
were performed after the primary and 
secondary antibody incubatio,ns. Sec-
tions were cover slipped after applica-
tion of Slowfade (Invitrogen). 
Fluorescence and transmitted 
light imaging. 
Tissues were examined with conven-
tional light and fluorescence micros-
copy using an Olympus BX51 micro-
scope equipped with an Optiscan 
z-axis controller (Prior Scientific) and 
supported on an anti-vibration table 
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(Technical Manufacturing Corpora-
tion, Peabody, MA). Images were cap-
tured using a Spot RT digital camera 
(Diagnostic Instruments) or a Retiga 
EXi digital camera (Qimaging) using 
Image Pro Plus software version 5.0 
(Media Cybernetics). High-resolution 
images were collected using an Opti 
grid structured light imaging system 
(QIOPTIC, Rochester, NY). A 100-W 
mercury lamp was used for epi-fluo-
rescence illumination with appropri-
ate excitation-emission filter sets for 
each ftuorophore. A laser-scanning 
confocal microscope (model LSM 510, 
Zeiss) was used for images in Figure 1. 
Images were reconstructed from con-
focal stacks of z-series scans as indi-
cated. 
Functional GI motility 
measurements. 
GI motility was assayed using live lar-
vae that were incubated in embryo 
medium containing blue food dye to 
enhance contrast of the GI tract lu-
men. The dye did not effect larvae sur-
vival, heart rate, or GI tract contrac-
tion frequency. Larvae were fully 
anesthetized and mounted laterally in 
1.2% agar to permit an optimal view-
ing of the GI tract, and to prevent drift 
during filming. A drop of anesthetic 
was placed on the agar to keep it from 
drying out and to keep larvae anesthe-
tized during filming. Spontaneous GI 
contractions were recorded continu-
ously for 10 min using a Cannon Op-
tura Xi digital video camera and con-
verted to digital format (Pinnacle 
Studio AVfDV). Contractions were 
counted manually at a single position 
in the mid-intestine during replay of 
digitized video at an increased rate. 
Reverse Transcriptase PCR. 
Experiments were done to determine 
if the zebrafish Kit receptors kita and 
kitb, and the Kit ligand (Steel factor) 
kitla and kitlb, are expressed in GI 
tissues. Total RNA was prepared from 
freshly dissected GI tissues of adult 
wild-type zebrafish, and from whole 
zebrafish (used as a positive control), 
using the RNeasy kit (Qiagen, Chats-
worth, CA). First-strand synthesis 
was performed using random decamer 
primers. Gene-specific PCR was per-
formed using Taq Pfx (Invitrogen) 
with 11-1-1 of the reaction mixture from 
the first-strand synthesis and pritp.ers 
specifically designed for each gene, 
and run for 35 cycles. Optimal magne-
sium concentration and primer an-
nealing temperature were indepen-
dently determined for each primer set. 
Amplification products were resolved 
on a 2.5% agarose gel. 
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Chapter 3: Molecular Biology 
Paralogs of the human genes Kit and Kit ligand are expressed 
within the zebrafish gastrointestinal tract. 
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Abstract 
The Kit receptor tyrosine kinase is expressed in the 
interstitial cell of Cajal (ICC), mast cells, and hematopoietic 
stem cells in the human gastrbintestinal (GI) tract. The 
zebrafish expresses two Kit orthologs, kita and kitb, which play 
a role in melanogenisis, but expression in the GI tract has not 
been reported. 1 Anti-Kit antibodies specifically identify two 
networks of cells located in the muscularis externa of the 
zebrafish GI tract, which suggests the existence of zebrafish 
ICC. This investigation confirms the expression of the zebrafish 
kit receptor genes, kita and kitb, as well as the kit ligand 
genes, kital and kitbl, within adult wild type zebrafish AB GI 
tissue. Confirmation of expression was achieved through reverse 
transcriptase PCR and sequencing of PCR products. These data 
show that kita, kitb, kital, and kitbl are expressed in zebrafish 
GI tissues. 
1. Introduction 
Kit is a tyrosine kinase receptor expressed on the cell 
surface of ICC within the GI tract and is necessary for the 
development and maintenance of ICC in humans and in mammalian 
model systems. 2• 3 Studies in mice have shown that the lack of the 
Kit receptor or its ligand, steel factor, leads to lesioning of 
ICC populations through an unknown process; leasioning of ICC 
appears not the result of apoptosis (negative TUNNLE assay) 
(personal communication to A. Rich from SJ Gibbons) . 4 Humans 
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with non-functional Kit alleles display deficiencies in ICC 
populations and GI motility disorders. 5- 7 Kit receptor expression 
and extracellular ligand are necessary for successful ICC cell 
culture. 8' 9 If ICC a+e present within the GI tract of the 
zebrafish, then if is likely that kit and kit ligand genes are 
expressed to support the development and maintenance of ICC 
populations. Alternatively, if the kit protein is not present 
within the GI tract of the zebrafish, observed Kit-like 
immunoreactivity would indicate a novel target in the zebrafish 
GI tract. 
The aim of this study is to define the expression profile 
of the Kit receptor gene paralogs, kita and kitb, and the Kit 
ligand paralogs, kitla and kitlb; if the kit receptor genes are 
expressed then it is likely that the anti-Kit antibody is 
reacting with the expressed zebrafish kita and/or kitb receptor 
tyrosine kinase. Both zebrafish kit receptors share antigenic 
sequence homology with the human Kit receptor; it is expected 
that both zebrafish kit receptors will be visualized with anti-
Kit antibodies. These experiments are a necessary step in 
characterizing the zebrafish as a model system for human GI 
motility. 
2. Materials and Methods 
2.1. Rational Qesign 
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Expression of the kit receptor and ligand genes were 
determined by reverse transcriptase polymerase chain reaction 
(RT-PCR) using total RNA isolated from the GI tract of adult wild 
type zebrafish (AB strain, obtained from the Zebrafish 
International Resource Center, ZIRC). Primer sets for each gene 
were specifically designed to discriminate genomic DNA 
contamination from eDNA by amplifying over intron-exon 
boundaries; therefore, products of vastly different size would 
result from amplification of genomic DNA over eDNA. Upon 
confirmation of proper PCR product amplification size, products 
were subcloned into vectors with universal prim~ng sites for DNA 
sequencing. Sequence data confirmed gene identification. 
2.2. Tissues, RNA Extraction, and eDNA Synthesis 
GI tissue was dissected from adult wild type zebrafish (AB 
strain, obtained from the Zebrafish International Resource 
Center, ZIRC) was immediately disrupted under liquid nitrogen 
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with a mortar and pestle, and homogenized using QIAshredder 
columns (QiageB). Total RNA was isolated with the RNeasy Protect 
Mini Kit (Qiagen). Integrity of the isolated total RNA was 
determined by formaldehyde gel electrophoresis. First strand 
synthesis was accomplished using the Reverse-IT 1st strand 
synthesis kit (ABgene), and utilized random decamers to prime 
RNA. 
2.3. PCR Primers 
Gene specific primers were designed for zebrafish kita, 
kitb, kitla, and kitlb using Integrated DNA Technology's web-
based primer design tool, Primer Quest 
(http://www.idtdna.com/Scitools/Applications/PrimerQuest/Default. 
aspx/). PCR primers specifically amplify products from each gene 
that crossed intron-exon boundaries. This approach enhances the 
quality of the molecular data by preventing PCR amplification 
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from genomic contamination. Primer sets were optimized for 
temperature and magnesium concentrations to produce sharp bands 
of expected size with the greatest amplification possible (table 
1). 
2.4. Cloning 
PCR products were confirmed by size for each gene using 
I 
agarose gel electrophoreses. PCR products of the expected sizes 
were inserted into pCR4Blunt-TOPO vectors (Invitrogen) and 
chemically transformed into One Shot TOPlO chemically competent 
cells (Invitrogen). Transformed cells were allowed to grow one 
hour at 37°C with rotation. Cells were then plated on LB plates 
with Ampicillin and allowed to grow overnight at 37°C to select 
for the presence of the pCR4Blunt-TOPO vector. Individual 
colonies were cultured in LB broth overnight at 37°C with 
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rotation. Plasmids were isolated from each culture with PureLink 
Quick Plasmid Miniprep kit (Invitrogen). Absorbance values for 
isolated plasmids were taken at 260nm and 280nm to determine 
purity and concentration of DNA. PCR utilizing M13 prime sites 
3' and 5' to the cloning site in the pCR4Blunt-TOPO vector and 
agarose gel electrophoresis were used to confirm the cloning of 
the proper insert into the cloning site. Plasmid DNA was 
sequenced by the Biotechnology Resource Center at Cornell 
University. 
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3. Results 
Total RNA was isolated from dissected adult zebrafish GI 
tissues using the RNeasy Protect Mini Kit (Qiagen). The 
integrity of isolated RNA was determined by formaldehyde gel 
electrophoresis (figure 1, lane B and F). Ribosomal RNA is 
highly expressed and is expected to show distinct bands at the 
appropriate size. Clear bands corresponding to 28s, 26s, and 18s 
rRNAs were observed. Total eDNA lacked strong bands correlating 
to rRNA (an indication of RNA contamination), and showed uniform 
smearing suggesting u~iform first strand synthesis (figure 1, 
lane D) . 
If the Kit and Kit ligand orthologs are expressed in the 
zebrafish GI tract then it will be possible to PCR amplify these 
gene products. PCR primers specifically designed for each Kit 
and Kit ligand gene orthologs. Primes were designed to cross 
intron-exon boundaries to minimize the possibility that genomic 
DNA would serve as template for PCR amplification. Expression of 
kita, kitb, kitla, and kitlb was determined using PCR on eDNA 
prepared from zebrafish GI tissues (figure 2). PCR products of 
the expected size were observed for each primer pair. PCR 
products were subcloned into sequencing vectors, and sequenced 
using Ml3 forward universal primer. 
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Sequence data of kita (figure 3), kitb (figure 4), kitla 
(figure 5), and kitlb (figure 6) were identical to the published 
sequences. These data confirm expression of the Kit receptor 
orthologs kita and kitb, and the Kit ligand orthologs kitla and 
kitlb within the wild type adult zebrafish GI tract. 
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Figure 1. Elec1rophoretogram ofzebrafish wild type 
AB total GI tract RNA and eDNA resolved on a 1.2% 
fonnaldehyde agarose geL Isolated total RNA (lane B 
and F) shows strong bands corresponding to 28s, 26s, 
and 18s rRNA RT-PCR was used to produce eDNA 
(lane D), which showed unifonn smearing; this pattern 
suggest successful first strand synthesis. Lanes A and G 
were loaded with exACTGene 50bp mini and 1 OObp 
PCRDNA ladders, respectively (Fisher Scientific). 
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Figure 2. Electrophoretogram of kita, kith, kit/a, and kitlh reverse 
transcriptase PCR products resolved on a 2.5% agarose gel. Lane A was 
loaded with exACTGene 50bp mini DNA ladder (Fisher Scientific). PCR 
products of the predicted size for primers designed to kita (564bp ), 
kith(234bp ), kit/a (580bp ), and kitlh (542bp) are shown in lanes B-E 
respectively. Primers designed to amplify fl-actin, yielded PCR products of 
expected size (lane F, 562bp ). 
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Figure 3. Kita reverse transcriptase PCR product sequence. Sequence data oonfinns GI 
specific expression of kita. Blastn search identifies Danio rerio kita with an expect value 
ofO. Sequence data aligns to 204bp-714bpofhtapublishedsequence(AF153446)with 
bl2seq. 
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Figure 4_ Kitb reverse transcriptase PCR product sequence. Sequence data confirms Gl 
specifiC expression of kitb. Blastn search identifies Danio rerio kitb with an expect value 
of 0. Sequence data aligns to 279bp- 513bp of kitb published sequence (DQ072166) with 
bl2seq. 
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Figure 5. Kit/a reverse transcriptase PCR product sequence. Sequence data confirms Gl 
specifiC expression of kit/a. Blastn search identifies Danio rerio kit/a with an expect value 
of 0. Sequence data aligns to 53bp- 634bp of kit/a published sequence (AY929068) with 
bl2seq. 
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Figure 6. Kitlb reverse transcriptase PCR product sequence. Sequence data confirms Gl 
specific expression of kit/b. Blastn search identifieS Danio rerio kitlb with an expect value 
of 0. Sequence data aligns to 202bp- 795bp of kitlb published sequence (AY929069) with 
bl2seq. 
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4. Discussion 
The data presented here show for the first time expression 
of mRNA encoding for the zebrafish kit receptors and kit ligands 
in the GI tract of adult wild type AB strain zebrafish; this is 
consistent with the hypothesis that coordination of GI motility 
requires interstitial cells of Cajal. These data contrast with 
published work by Parichy et al., where kit expression was not 
observed within the GI tract of zebrafish. 1 One potential 
explanation for the discrepancy is that kit expression was 
measured 48 hours post-fertilization (personal communication to 
A. Rich from S. Johnson). Expression of the kit receptors within 
the GI tract may not be detectable until later in development; in 
the murine GI tract, expression of Kit occurs between embryonic 
day 11 and 15. 10 ' 11 Therefore, it is possible that kita and kitb 
expression occur after 2 days post fertilization, and that 
putative ICC develop after this developmental stage. 
Sequencing of PCR products from gene specific priming 
confirmed the reverse transcriptase PCR based expression profile 
of the kit genes. Sequenced portions of genes suggest that 
tissue specific variations of the kit genes are not present. 
However, it is possible that tissue specific variants may occur 
in non-sequenced portions. The data suggest that kita and kitla 
were expressed at higher levels when compared to kitb or kitlb. 
The differences in expression level can be seen by ethidium 
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bromide staining of gels utilized to separate the PCR products by 
size. Further experiments are necessary to verify this 
observation. 
The human GI tract is a complex syncytium of tissues 
including smooth muscle, neurons, ICC, connective, epithelial, 
' 
and immune cells. This work shows expression at the mRNA level 
I 
~f two orthologs for the human Kit gene, kita and kitb, and two 
orthologs for human Kit ligand, kitla and kitlb. These results 
are consistent with previous reports that identify putative ICC 
in the zebrafish GI tract using antibodies to the human Kit 
protein. 7 It is possible that mast cells located within the 
zebrafish tunica muscularis express kita and kitb, Kit expression 
by mast cells has been well documented. 12 ' 13 However, mast cells 
are spherical and anti-Kit antibodies specificall~ identified 
slender bipolar or stellate-shaped cells, which are morphological 
features that characterize ICC. Future experiments are necessary 
to unambiguously identify ICC in the zebrafish using electron 
microscopy, and to determine the physiological role for ICC in 
the zebrafish GI tract. 
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General Results and Conclusions 
Intestinal cells of Cajal (ICC) within the gastrointestinal 
(GI) tracts of mammals, function as regulators of the electrical 
slow wave, which coordinates the contraction of GI smooth muscle. 
The coordinated contraction of GI smooth muscle propels luminal 
contents aoraly in an ordered manner; this coordinated movement 
of luminal contents aoraly is termed coordinated GI motility. To 
pe~form the function of slow wave regulators, ICC have a 
functionally critical anatomical position, juxtaposed between 
smooth muscle and enteric neurons. ICC integrate neural stimulus 
and distribute information to smooth muscle cells to regulate 
coordinated smooth muscle contractions. ICC within the myenteric 
plexus of the GI tract are the most important subclass of ICC to 
coordinated motility. Singly dispersed ICC within the muscular 
layers a~t locally to help regulate smooth muscle electrical 
activity, and ICC within the deep muscular plexus also have been 
shown to regulate GI smooth muscle contractions. 
ICC require Kit receptor surface expression and Kit ligand 
in the extracellular space for development and maintenance. ICC 
are most commonly identified by Kit immunoreactivity; however, 
Kit is expressed by hematopoietic stem cells and mast cells. 
Thus, cell morphology and anatomical positioning must also be 
considered when evaluating Kit immunohistochemistry. ICC have 
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two classic morphologies, stellate shaped cells and bipolar cells 
with enlarged cell bodies and slender processes. Hematopoietic 
and mast cells generally are spherical, with mast cells having a 
much larger volume; mast cells may also have oblate ellipsoid 
morphology, especiall~ during diapedisis and degranulation. 
Additionally, mast cells and hematopoietic cells are rarely found 
within the muscular tunic, which is the location of ICC within 
the GI tract. With care it is quite simple to distinguish Kit 
immunoreactivity cells biased on cell morphology and cell 
anatomy, making differential staining unnecessary. 
ICC populations within the zebrafish GI tract have been 
investigated in this thesis to support the zebrafish as a model 
for GI motility. Current models for GI motility have yielded few 
therapeutics for GI motility disorders, thus, a new model is 
needed. The main advantage of the zebrafish as a model system 
for GI motility_ is the transparency of the zebrafish larvae. The 
zebrafish has a fully functionally GI tract by 4-5 days post 
fertilization (dpf), which is easily observable with low power 
light microscopy. It may be possible to take advantage of the 
optic transparency of zebrafish larvae to develop high-throughput 
drug screens for GI motility disorders. The presence of ICC 
within the zebrafish GI tract is fundamental to the utility of 
the zebrafish as a model for GI motility. Lesions in ICC 
populations (particularly ICC within the myentric plexus) are 
directly linked to motility disorders in humans and mice. 
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Validating the presence of ICC within the zebrafish GI tract is 
therefore imperative to the utility of the zebrafish as a model 
for GI motility. 
) 
This investi~ation has shown immunohistochemically two 
distinct populations of ICC within the zebrafish GI tract. A 
dense layer of ICC is present within the myenteric plexus region 
of the zebrafish GI tract; these myenteric ICC are closely 
associated with enteric neuron cell bodies and processes. An 
adpitional, less dense layer of ICC are present within the deep 
muscular plexus. The deep muscular ICC are closely associated 
with neural processes originating from neural cell bodies within 
the myenteric plexus. 
The anti-Kit antibody utilized within this study, abl6832 
(Abeam), was generated to target human Kit protein. It is 
possible that the anti-Kit antibody does not target zebrafish kit 
receptors, and instead binds to an unknown protein correlating to 
a novel cell type. It was necessary to support 
immunohistochemical data with expression data due to the lack of 
knowledge about anti-Kit antibody reactivity within the zebrafish 
GI tract. Since Kit and Kit ligand are essential to ICC 
development and maintenance in mammalian systems, expression of 
mRNA for the kit receptor genes and kit receptor ligand genes 
supports the notion that ICC are present within the zebrafish GI 
tract. GI specific expression of the two zebrafish kit receptor 
genes, kita and kitb, and the kit receptor ligand genes, kitla 
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and kitlb, has been determined by work presented in this thesis. 
Expression data was investigated with a reverse transcriptase PCR 
approach, and verified with sequencing of reverse transcription 
PCR product. GI specific expression of kita, kitb, kitla, and 
kitlb supports both Kit immunoreactivity within the zebrafish GI 
tract, and ICC presence within the GI tract of the zebrafish. 
For the first time in zebrafish GI specific expression of kita, 
kitb, kitla, and kitlb is confirmed. This thesis concludes ICC 
are present in two populations within the GI tract of the 
zebrafish, a deep muscular plexus population and a myenteric 
plexus population. 
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Protocol 1.1. 25X MESAB 
400mg Tricaine 
97.9mL diH20 
2.1ml of 1M Tris pH 9.0 
pH to 7.0-7.4 
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Protocol 1.2 lX MESAB 
Add 1 volume of 25X MESAB to 24 volumes fish water or E3 media. 
100 
Protocol 1.3 4% Paraformaldahyde 
Note of caution - always work with paraformaldahyde under the 
fumehood. Do not inhale powder or vapors from solution, and clean 
all areas to protect coworkers. 
1. Add 0.4g of paraformaldahyde to 90m1 of diH20 in an Erlenmeyer 
flask (to minimize evaporation) . 
2. Add three drops of 1M NaOH. 
3. H~at solution at 55- 60°C until all solid has dissolved (1- 3 
hours). It is important not to heat solution above 60°C and 
to keep solution covered with a watch glass to prevent 
evaporation. 
4. Cool solution in an ice bath for 10 minutss. 
5. Add 10m1 of lOX PBS to cooled solution. 
6. pH to 7.4 with 1M NaOH or 1M HCl. 
Solution should be made on the day of use or frozen at -20°C 
until use. 
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Protocol 1.4 Anesthetizing Fish or Larvae 
1. Place fish or larvae in lX MESAB. 
2. Wait two minutes and check somatic reflexes by touching 
fish with a pipette or gently agitating larvae with a blast 
of lX MESAB. If the fish or larvae do not respond, they 
are fully anesthetized. If they respond to stimulus, give 
MESAB more time and check again. 
102 
Protocol 1.5 Adult Zebrafish Fixation 
1. Fast fish for three days prior to fixation. 
2. Head and tail may be removed to aid fixation. 
3. Place fish in 4% paraformaldehyde. 
4. Incubate overnight at 4°C. 
5. Wash fish in two changes of diH20 for 5 minutes for whole 
processing; alternatively, dissect out GI tract or other 
tissues in PBS followed by two washes in diH20 for 5 
minutes. For whole mount staining do not proceeded to step 
6, this step is for tissues or fish to be paraffin 
embedded. 
6. Place fish tissue in processing cassettes and wash in 70% 
ethanol for 10 minutes, then place cassettes into tissue 
processor. If whole fish are to be paraffin embedded skip 
step 6 and decalcify fish. 
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Protocol 1.6 Larvae Zebrafish Fixation 
1. Fast fish for three days prior to fixation. 
2. Place fish in 4% paraformaldehyde. 
3. Incubate overnight at 4°C. 
4. For larvae, which will be paraffin-embedded, wash fish in 
two changes of diH20 for 5 minutes a wash; proceed to 
step 5. If larvae are to be used for whole mount 
staining, wash in two changes of PBS for 5 minutes a 
wash; proceed to immunostaining, peeling larvae if 
necessary, do not complete steps 5-13. 
5. Heat Histogel for 3- 5 minutes in 100°C water bath, or 
until fully liquefied. 
6. Drop water bath temperature to 50- 60°C, and allow 
Histogel temperature to equilibrate. 
7. Place larvae on a clean glass slide. Remove as much 
liquid as possible by wicking off excess liquid with a 
Kimwipe. 
8. Position larvae in desired orientation; paint brushes 
work well for this. 
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9. To one side of the larvae, place a drop of Histogel. 
Allow the Histogel. Allow the Histogel to slowly flow 
onto the larvae; avoid disturbing the desired 
orientation. If orientation is disturbed, quickly 
reposition the larvae with a micro spatula or paint brush 
before Histogel sets. 
10. Fully cover the larvae with additional Histogel if 
necessary; allow Histogel to fully set. 
11. Cut square/rectangle out Histogel button; make sure to 
cut sectioning face at 90° to make positioning during 
mold casting easier. 
12. Remove Histogel rectangle from the slide using a razor 
blade as a spatula. 
13. Place larvae in processing cassette; wash in 70% ethanol 
for 10 minutes before placing cassette into tissue 
processor. 
Protocol 1.7 Decalcification Protocol 
Stock Ammonium Hydroxide: 
70mL concentrated ammonium hydroxide 
750mL of diH20 
Stock Decalcification Solution: 
1. Add 82mL of stock ammonium hydroxide to 1g of EDTA (MW 
292.24). 
2. Add more EDTA or ammonium hydroxide stock to bring the pH 
of the solution to 7.2. EDTA will decrease pH, while 
ammonium hydroxide will increase pH. Large quantities of 
EDTA usually have to be added to attain pH 7.2; pH change 
will be slow at pH values above pH 8, but will change 
rapidly from pH 8- pH 7.2. 
3. Bring solution volume to 100mL with diH20. 
Decalcification of Adult Zebrafish: 
1. Post fixation, rinse zebrafish in PBS once for 5 minutes. 
2. Next, rinse zebrafish with stock decalcification solution 
for 5 minutes (this can be previously used or fresh 
solution) . 
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3. Place zebrafish in at. least lOX volume of stock 
decalcification solution. Incubate for 24- 48 hours at 
room temperature or 4°C with rotation. When 
decalcification is complete, spinal columns can be cut with 
little resistance and no brittleness. 
4. Tissues are now ready for paraffin infiltration 
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Protocol 1.8 Tissue Processing Schedules: Zebrafish 
Larvae 
Utilize the following tissue processing schedule for automated 
tissue processing. Make sure to log all usages, solutions must 
be rotated every 5 runs. Also, make sure to remove tissue prior 
to running cleaning cycle. 
Zebrafish Larvae Processing Schedule 
Reagent Temperature Time P/V 
70% ETOH 35 oc 30 minutes No 
95% ETOH 35 oc 30 minutes No 
95% ETOH 35 oc 30 minutes No 
100% ETOH 35 oc 20 minutes No 
100% ETOH 35 oc 20 minutes No 
100% ETOH 35 oc 20 minutes No 
100% ETOH 35 oc 20 minutes No 
XYLENE 35 oc 30 minutes No 
XYLENE 35 oc 30 minutes No 
XYLENE 35 oc 30 minutes Yes 
PARAFFIN 60 oc 15 minutes Yes 
PARAFFIN 60 oc 15 minutes Yes 
PARAFFIN 60 oc 15 minutes Yes 
PARAFFIN 60 oc 15 minutes Yes 
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Protocol 1.9 Tissue Processing Schedules: Whole Zebrafish 
and GI Tract 
Utilize the following tissue processing schedule for automated 
tissue processing. Make sure to log all usages, solutions must 
be rotated every 5 runs. Also, make sure to remove tissue prior 
to running cleaning cycle. 
Zebrafish Adult Whole Fish and Whole GI Tract Processing 
Schedule 
Reagent Temperature Time P/V 
70% ETOH 35 oc 1 hour No 
95% ETOH 35 oc 1 hour ' No 
95% ETOH 35 oc 1 hour Yes 
100% ETOH 35 oc 1 hour No 
100% ETOH 35 oc 1 hour No 
100% ETOH 35 oc 1 hour No 
100% ETOH 35 oc 1 hour Yes 
XYLENE 35 oc 1 hour No 
XYLENE 35 oc 1 hour No 
XYLENE 35 oc 1 hour Yes 
PARAFFIN 60 oc 30 minutes Yes 
PARAFFIN 60 oc 30 minutes Yes 
PARAFFIN 60 oc 30 minutes Yes 
PARAFFIN 60 oc 30 minutes Yes 
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Protocol 1.10 Tissue Embedding 
1. Preheat embedder for about 2 hours. Make sure both 
reservoirs are fully melted before beginning work. The 
machine is programmable to began work at predestinated 
times, but these times need to be set for 2 hours prior 
to actual start times. Auto start feature must be turned 
off after work period, or work times being held for all 
future weeks. 
2. All working surfaces of embedder should be sprayed 
lightly with paraffin release agents. 
3. Molds should be prewarmed on heated surface to remove 
residual wax, sprayed with paraffin release agents, and 
then place upside down to allow residual release agents 
to drain prior to casting the mold. 
4. Drain retort of tissue processor by pressing the start 
button. Machine will beep when the process is completed. 
5. Remove safety bar by sliding it to the left; this will 
cause the machine to beep. 
6. Unlatch the retort and the open lid. 
7. Remove cassette from the retort cage. 
8. Place cassette in the paraffin bath reservoir of the 
tissue embedder; allow tissue to equilibrate for 10 
minutes. 
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9. Open the cassette and alter sample if necessary (trim, 
dissect, or straighten); for example, whole GI tract need 
to be cut into anterior, posterior, and middle portions. 
When altering tissue, it is very important not to loose 
orientation; this is very, very easy to do. 
10. Trigger paraffin dispensing with the foot peddle to clear 
lines. 
11. Collect a small amount of paraffin in the mold (about ~ 
of block volume), and touch mold bottom to the cold 
surface, in an effort to form a thin skin on the bottom 
of the mold. 
12. Place tissue into the mold and orient; if paraffin sets 
before orientation is achieved, place mold on the hot 
surface to melt. 
13. Once tissue is in proper orientation (and paraffin is 
still molten- very important), place a cassette back on 
the top of the mold. 
14. Dispense paraffin onto the cassette back, completely 
filling the mold and the cassette back. 
15. Place the mold on the cold surface and let set for 30 
minutes. 
16. Remove the block from the mold very carefully. Usually, 
trimming the excess paraffin from the mold will release 
the block; avoid pulling on the cassette back to remove 
block from mold. 
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17. Store blocks in refrigerator until use. 
Protocol 1.11 Sectioning Paraffin Embedded Tissue 
1. Cut the block face with a new razor blade as evenly as 
possible to expose tissue. 
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2. Trim block face to minimize paraffin surrounding tissue, 
yet keeping square shape. It is often desirable to leave 
an untrimmed face on the edge of th~ block that will 
strike the knife first on the down stroke; this seems to 
facilitate better ribboning. 
3. Rehydrate block in diH20 ice bath for 30 minutes. 
4. Set up room temperature diH20 bath and 56-58°C diH20 
bath. 
5. Clean sectioning knife with xylene and allow to 
completely dry. 
6. Lock the advancing arm in place, and place the block into 
the block holder. 
7. Position knife in knife holder. Make sure the cutting 
face points up and is as level as possible; also align 
the knife so that the bevel is slightly above the knife 
holder's face. Clamp knife into place. 
8. Adjust knife angle to about 5°. 
9. Adjust the block face to make it parallel with the knife. 
Also, adjust the block face to make the top and bottom 
equal distance from the knife during the cutting stroke. 
10. Move the knife holder as close as possible to the block 
without touching it; lock knife holder in place. 
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11. Unlock the block advance arm, and rotate it clockwise to 
begin cutting. 
12. Advance arm until cutting of the block begins. Observe 
which parts of the block are being cut, and for example 
adjust as follows: if the bottom of the block is cutting, 
but the top is not, adjust the block so that the top of 
the block come slightly forward and the bottom of the 
block comes slightly back. Make sure to lock the knife 
advancement arm before adjusting the block. 
13. Once uniform sections are being cut, if proper ribboning 
is not achieved, adjust the knife angle. 
14. Once uniform cutting and ribbioning are achieved transfer 
sections with paint brushes to the surface of a room 
temperature water bath; sections should spread out and 
uncurl. It is sometimes necessary to unroll the sections 
with paint brushes. 
15. Collect sections on a slide by inserting the slide into 
the room temperature water bath at 45°; contacting the 
edge of the section with the adhesive treated surface; 
using a brush or another slide, if necessary, to coax 
sections into contacting the slides in desired 
orientation; and finally, slowly withdraw the slide from 
the water bath at 45°. 
16. Inserting the slide with sections into a 56- 58°C diH20 
bath at 45°, make sure to retain contact between the 
slide and the very last position of section; sections 
will shrink slightly and fully unwrinkled. 
17. Slowly withdraw the slide from the bath at 45° to avoid 
trapping water under the paraffin sections. 
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18. Place the slide in a drying rack at 90- 45° to dry for 1 
hour. 
19. Touch end of the slide to an absorptive surface to wick 
off excess water. 
20. Place the slide onto a slide dryer or hot plate for 1 
hour to overnight at 56- 58°C. 
21. Store slides at -20°C wrapped in parafilm 
22. Also see attached video entitled tissue sectioning. 
Appendix 1.2: Protocols 
Immunohistochemistry 
Scott Leddon 
Department of Biological Sciences 
State University of New York College at Brockport 
Brockport, New York 
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Protocol 2.1 PBS 0.02% Sodium Azide 
lOOmL of lOX PBS 
900mL of type 1 H20 
0.2g sodium azide 
pH to 7.0- 7.4 
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Protocol 2.2 0.1% 0.05% PBSTT 
Add lOO~L of Triton X-100 and 50~L of Tween 20 to 99.85rnL of PBS 
0.02% sodium azide, and gently mix (do not shake) until Triton is 
dissolved. 
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Protocol 2.3 0.1% 0.05% PBSTT 10% NDS 
- This is blocking solution. 
Add lmL of NOS (or normal serum of the secondary Ab host) to 9mL 
of 0.1% 0.05% PBSTT, mix gently (do not shake). 
Protocol 2.4 0.1% 0.05% PBSTT 5% NOS 
-This is used for Ab 1° dilution. 
Add 0.5mL of NOS (or normal serum of the secondary Ab host) to 
9.5mL of 0.1% 0.05% PBSTT, and gently mix (do not shake). 
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Protocol 2.5 0.1% 0.05% PBSTT 2.5% NDS 
- This is used for Ab 2° dilution. 
Add 0.25mL of NDS (or normal serum of the secondary Ab host) to 
9.75mL of 0.1% 0.05% PBSTT, and gently mix (do not shake). 
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Protocol 2.6 1° AbSolution 
Dilute Ab 100-SOOX with 0.1% 0.05% PBSTT 0.5% NOS. 
• Dilution factors vary between Ab. 
• When dual staining make sure 1° Abare raised in 
different organisms, and make dilutions one-half as 
dilute as the final working concentration; this allows 
the combination of two equal volumes of 1° Abs to 
achieve proper final dilutions. 
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Protocol 2.7 2° AbSolution 
Dilute Ab 100-SOOX with 0.1% 0.05% PBSTT 0.25% NOS. 
• Dilution factor vary between Ab. 
• When dual staining make sure 2° Ab do not have the 
same conjugate, and that the conjugates excitation and 
emission (most important) wavelengths do not overlap. 
Make dilutions one-half as dilute as the final working 
concentration; this allows the combination of two 
equal volumes of 2° Abs to achieve proper final 
dilutions. 
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Protocol 2.8 Citraconic Acid Antigen Retrieval Solution 
400~L of citraconic anhydride 
lOOOmL of deionized water 
pH to 7.4 with 10M NaOH 
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Protocol 2.9 Citrate Antigen Retrieval Solution 
2.94g of trisodium citrate dehydrate 
lOOOmL of deionized water 
500pL of Tween 20 (gently mix to dissolve Tween 20) 
pH to 6.0 with 10M HCl 
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Protocol 2.10 Tris EDTA Buffer (SOmM Tris, lmM EDTA, pH 
8.0) 
6.10g of Tris base 
0.37g EDTA 
lOOOmL of deionized water 
pH to 8.0 with 10M HCl 
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Protocol 2.11 Proteinase K Antigen Retrieval Solution 
0.2g of proteinase K 
lOOmL of Tris EDTA buffer 
Final concentration of 20pg/m1 
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Protocol 2.12 Abeam Retrieval Solution 
Dilute lOX commercially available stock to working concentrations 
by addin~ 1 part lOX stock to 9 parts deionized water. 
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Protocol 2.13 Dako Antigen Retrieval Solution 
Dilute lOX commercially available stock to working concentrations 
by adding 1 part lOX stock to 9 parts deionized water. 
Protocol 2.14 Deparaffinization of Sectioned Tissues 
1. Set up the following stations in respective flow: xylene, 
xylene, 100% EtOH, 100% EtOH, 95% EtOH, 95% EtOH, PBS. 
• The first xylene, 100% EtOH, and 95% EtOH should be 
rotated out every five processing sessions or when 
precipitate forms. 
• Only dispose of xylene in a xylene waste receptacle. 
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EtOH that has been contaminated with paraffin or 
xylene should be only disposed of in a mixed organics 
EtOH receptacle. 
2. Place baked slides in slide carriage, and pass through 
above stages. The slides should be in each xylene stage 
for 5 minutes, each EtOH stage for 3 minutes, and PBS for 
20- 30 minutes. 
• Between stations, slides should be tapped off to rid 
the slide of excess liquid; do not allow tissues to 
dry. 
• If when placing slides into a new station, the station 
becomes cloudy- immediately change the station, your 
slides should be salvageable. 
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Protocol 2.15 Antigen Retrieval 
Use antigen retrieval only when necessary. Different tissue 
preparations, antigens, and fixation times all can affect antigen 
retrieval outcome. A battery of solutions should be tested on 
samples that have previously not been optimized. Temperature, 
incubation time, pH, heating methods, and length of retrieval all 
influence success; it may be necessary to alter these conditions 
t·o ensure success. 
Use the following procedure when using non-enzymatic antigen 
retrieval solutions: 
1. Heat solution to 100°C in a circulating water bath. 
2. Place slide or samples in solution. 
3. Incubate for 20 minutes. 
4. Remove antigen retrieval solution (still containing 
samples) from water bath, and allow cooling at room 
temperature for 20 minutes. 
5. Wash 2X in 0.1% 0.05% PBSTT for 5 minutes a wash. 
Use the following procedure when using enzymatic antigen 
retrieval solutions: 
1. Heat solution to 37°C (or to temperature optimal for 
enzymatic reaction) in a circulating water bath. 
2. Place slide or samples in solution. 
3. Incubate for 10 minutes. 
4. Remove antigen retrieval solution (still containing 
Sqmples) from water bath, and allow cooling at room 
temperature for 10 minutes. 
5. Wash 2X in 0.1% 0.05% PBSTT for 5 minutes a wash. 
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Protocol 2.16 Quick Immunostaining 
The following protocol is for sectioned tissue on slides. 
If whole mounts are being stained, simply use scintillation 
or micro-well plates for solution changes, and begin at 
step 2. Place samples in well slides after step 6. 
~otation may also be used for whole mount incubations and 
washes. 
1. Dry area around tissue with a vacuum, and then use a pap 
pen to outline the tissue on the slides (pap pens will not 
work properly if used on a wet surface) . Remember to work 
fast to avoid drying out the tissue. 
2. Gently pipette blocking solution (0.1% 0.05% PBSTT 10% NDS) 
onto the tissue section, using enough to cover tissue. 
Incubate at room temperature for 1 hour (cover with a Petri 
dish to avoid evaporation, and check slides periodically to 
make sure the blocking solution does not evaporate, add 
more if necessary) . 
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3. Gently vacuum off blocking solution, and gently pipette 
enough 1° Ab to fully cover tissue. Incubate at room 
temperature for 1 hour (cover with a Petri dish to avoid 
evaporation-also check slides periodically to make sure the 
1° Ab does not evaporate, add more if necessary). 
4. Gently vacuum off 1° Ab. Gently pipette 0.1% 0.05% PBSTT 
onto fhe tissue section, using enough to cover tissue. 
Incudate for 5 minutes, and then gently vacuum off 0.1% 
0.05% PBSTT. Repeat this step for a total of three washes. 
5. Gently vacuum off 0.1% 0.05% PBSTT, and gently pipette 
enough 2° Ab to fully cover tissue. Incubate at room 
temperature for 1 hour (cover with a Petri dish to avoid 
evaporation, and check slides periodically to make sure the 
2° Ab does not evaporate, add more if necessary). 
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6. Gently vacuum off 2° Ab. Gently pipette 0.1% 0.05% PBSTT 
onto the tissue section, useing enough to cover tissue. 
Incubate for 5 minutes, and then gently vacuum off 0.1% 
0.05% PBSTT. Repeat this step for a total of three washes. 
7. Apply one small drop of Slow Fade compound A (Invitrogen) 
to the tissue sample and coverslip. The slides are now 
ready for observation. 
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Protocol 2.17 Long Immunostaining 
The following protocol is for sectioned tissue on slides. 
If whole mounts are being stained, simply use scintillation 
or micro-well plates for solution changes, and begin at 
step 2. Place samples in well slides after step 6. 
Rotation may also be used for whole mount incubations and 
washes. 
1. Dry area around tissue with a vacuum, and then use a pap 
pen to outline the tissue on the slides (pap pens will not 
work properly if used on a wet surface). Remember to work 
fast to avoid drying out the tissue. 
2. Gently pipette blocking solution (0.1% 0.05% PBSTT 10% NOS) 
onto the tissue section, using enough to cover tissue. 
Incubate at room temperature for 1 hour (cover with a Petri 
dish to avoid evaporation, and check slides periodically to 
make sure the blocking solution does not evaporate, add 
more if necessary) . 
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3. Gently vacuum off blocking solution, and gently pipette 
enough 1° Ab to fully cover tissue. Incubate at 4°C for 8 
hours or overnight (cover with a Petri dish to avoid 
evaporation) . 
4. Gently vacuum off 1° Ab. Gently pipette 0.1% 0.05% PBSTT 
onto the tissue section, using enough to cover tissue. 
Incubate for 5 minutes, and then gently vacuum off 0.1% 
0.05% PBSTT. Repeat this step for a total of three washes. 
5. Gently va~uum off 0.1% 0.05% PBSTT, and gently pipette 
enough 2° Ab to fully cover tissue. Incubate at 4°C for 8 
hours or overnight (cover with a Petri dish to avoid 
evaporation) . 
6. Gently vacuum off 2° Ab. Gently pipette 0.1% 0.05% PBSTT 
onto the tissue section, using enough to cover tissue. 
Incubate for 5 minutes, and then gently vacuum off 0.1% 
0.05% PBSTT. Repeat this step for a total of three washes. 
7. Apply one small drop of Slow Fade compound A (Invitrogen) 
to the tissue sample and coverslip. The slides are now 
ready for observation. 
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Appendix 1.3: Protocols 
RNA Isolation to eDNA 
Scott Leddon 
Department of Biological Sciences 
State University of New York College at Brockport 
Brockport, New York 
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Protocol 3.1 DEPC Treated H20 (0.1% DEPC) 
1mL DEPC 
999mL diH20 
1. Shake vigorously until DEPC is fully dissolved. 
2. Incubate 12 hours at 37°C. 
3. Autoclave or heat to 100°C for 15 minutes. 
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Protocol 3.2 lOX Formaldehyde Gel Buffer 
200mM 3-[N-morpholino]propanesulfonic acid (MOPS) (free 
acid)- MW 202.26 
SOmM sodium acetate- MW 136.08 
lOmM EDTA- MW 292.24 
pH to 7.0 with 1M NaOH 
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Protocol 3.3 lX Formaldehyde Gel Running Buffer 
lOOmL lOX formaldehyde gel buffer 
20mL 37% (12.3 M) formaldehyde 
880mL RNase-free H20 (DEPC treated) 
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Protocol 3.4 SX RNA Loading Buffer 
16~L saturated bromophenol blue solution 
80~L 500mM EDTA, pH 8.0- MW 292.24 
720~L 37% (12.3 M) formaldehyde 
2000~L 100% glycerol 
3084~L formamide 
4000~L lOX formaldehyde gel buffer 
lOO~L RNase-free H20 (DEPC treated) 
Protocol 3.5 1.2% Formaldehyde Gel (50mL) 
0.6g agarose 
SmL of lOX formaldehyde gel buffer 
45mL of RNase-free H20 (DEPC treated) 
1. Add the above to an 250mL Erlenmeyer flask (to minimize 
evaporation) . 
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2. Heat in the microwave until agarose is fully dissolved, do 
not allow to over boil. 
3. Cool solution to 65°C, and add under a fumehood O.SpL of 
lOmg/mL ethidium bromide and 900pL of 37% (12.3M) 
formaldehyde. 
4. Mix well, pour into mold, and allow to set for 30 minutes 
at room temperature. 
5. Remove gel from mold and place in electrophoresis 
containing lX formaldehyde gel running buffer. 
6. Allow gel to equilibrate with buffer for 30 minutes prior 
to loading gel. 
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Protocol 3.6 RNA Isolation RN~asy Mini Kit 
1. 10mg- 30mg of tissue as starting material (excess tissue 
can cause the column to clog or supersede lysis buffer 
capacity, resulting in inefficient RNA isolation). Ware 
gloves and treat all surfaces including your table, 
gloves, and dissection tools with RNAaway to degrade 
exogenous RNAases. 
2. Stabilize RNA with RNAlater for best results prior to 
total mRNA isolation. 
3. Excise fresh tissue and cut into sections of O.Scm or 
less (one dimension to insure penetration) . Immediately 
place tissue in the appropriate volume of RNAlater; 10pl 
per 1mg of tissue or more is ap~ropriate, tissue needs to 
be fully submerged. 
4. ~-mercaptoethanol (bad stuff- gloves and hood) must be 
added to Buffer RLT before use. Add 10pl of ~­
mercaptoethanol per 1ml of Buffer RLT (stable for 1 
month). Buffer RPE needs to be diluted with 100% EtOH 
before first use (add 4 volumes of EtOH before use) . 
5. Remove tissue from RNAlater with forceps. Do not use 
more than 30 mg. Place in a homogenizing vessel with 
liquid nitrogen. Grind thoroughly and allow liquid 
nitrogen to evaporate, but do not let tissue thaw. Add 
350pl (under 20mg of tissue) to 600pl (20mg -30mg of 
tissue) of Buffer RLT. Use additional Buffer RLT for 
hard to lyse tissues. 
6. Pass ground tissue through an RNase free syringe with a 
20-gauge needle at least 5X. 
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7. Centrifuge the tissue lysate for 3 minutes at max speed 
in a microcentrifuge. Transfer the supernate to a new 
tube. In some preps the pellet may be invisible, do not 
transfer. Use only the supernate (lysate) in the 
remaining steps. 
8. Add one volume of 70% EtOH to lysate and mix immediately 
by pipetteing, move to the next step. 
9. Add up to 700pl of the sample (including any precipitate) 
to a spin column placed in a 2 ml collection tube. Close 
and centrifuge for 15 s at less than 8000 g (10000 rpm}. 
Discard flow through. If you have more sample, repeat. 
10. Add 700pl Buffer RW1 to the RNeasy column. Close and 
centrifuge for 15 s at less than 8000 g (10000 rpm) . 
Discard flow through. 
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11. Transfer the column to a new collection tube. Add 500~1 
of Buffer RPE to column, close, and centrifuge for 15s at 
less than 8000g (10000rpm). Discard flow through. 
Before using RPE for the first time it must be diluted 
see above 
12. Add another Add 500~1 of Buffer RPE to column, close, and 
centrifuge for 2 minutes at less than 8000g (10000rpm) . 
Discard flow through. 
13. Place column in a fresh collection tube, and centrifuge 
at max speed for 1 minute. 
14. To elute, place column in a new 1.5ml collection tube, 
and add 30- 50~1 of RNase-free water onto the filter. 
Close and centrifuge for 1 minute at less than 8000 g 
( 1 0 0 0 0 rpm) . 
15. Analyze RNA integrity by formaldehyde gel 
electrophoresis. 
16. Analyze RNA purity through Abs2 60 /Abs2so· 
17. Analyze RNA concentration through Abs2 6o. 
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Protocol 3.7 1.2% Formaldehyde Gel Electrophoresis 
1. Add 3pL of 5X RNA loading buffer to 12pL of RNA sample. 
2. Incubate at 65°C for 3- 5 minutes. 
3. Chill on ice for 1 minute. 
4. Load sample into equilibrated formaldehyde gel. 
5. Run gel at 100mV for 2 minutes. 
6. Lower voltage to 70mV until desired separation is archived. 
Protocol 3.8 RNA Concentration 
1. Utilize 10mM Tris·Cl pH 7.5 to zero spectrophotometer. 
2. Dilute RNA 1:50 to 1:1000 in 10mM Tris·Cl pH 7.5, for 
absorbance values to be accurate the absorbance should be 
between 1.0- 0.15. 
3. Measure A26o. 
4. [RNA] ].lg/mL 40 X A260 X dilution factor (1:100 . 100) X 
light path (em). 
5. RNA yield ].lg = [RNA]].lg/mL X volume sample mL. 
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Protocol 3. 9 RNA Purity (A2so/A2so) 
1. Utilize lOmM Tris·Cl pH 7.5 to zero spectrophotometer. 
2. Dilute RNA 1:100 to 1:1000 in lOmM Tris·Cl pH 7.5, for 
absorbance values to be accurate the absorbance should be 
between 1.0- 0.15. 
3. Measure A26o and A2so. 
4. Pure RNA has a A260 /A2ao ratio ranging from 1. 9- 2. 3. 
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Protocol 3.10.cDNA 1st Strand: ABgene Reverse-iT 1st Strand 
Synthesis Kit - 2 Step Protocol 
la. Mix the following in a thin walled PCR tube (Reaction 
Tube) : 
• 3pL of total RNA (300ng) 
• lpl of random decamers {purple cap 400ng/lpl) 
• 8pl RNase free water 
lb. Mix the following in a thin walled PCR tube (Control 
Tube) : 
• lpL of MS2 positive control RNA 
• lpl of random decamers (purple cap 400ng/lpl) 
• lOpl RNase free water 
2. Heat to 70°C for 5 minutes, then place on ice. 
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3. Add the following to each PCR tube: 
• 4~1 5X first strand synthesis buffer (red cap) 
• 2~1 dNTP mix, 5mM each (green cap) 
• 1~1 Reverse-iT RTase blend (clear cap) 
• 1~1 DDT 100mM (yellow cap) 
4. Incubate tube at 47°C for 50 minutes. 
5. Inactivate Reverse-iT RTase blend by incubating tube at 
75°C for 10 minutes. 
6. Store at -20°C. 
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Control (MS2) PCR for Re~erse Transcription Reaction 
1. Mix the following in a PCR tube: 
2.50~L lOX buffer 
0.75~L lOmM DNTP 
O.SO~L template 
0.20~L PFX 
19.05~L DNase free water 
O.SO~L SOmM MgS04 
0.75~L 20pmole/~L forward primer 
0.75~L 20pmole/~L reverse primer 
TOTAL VOLUME 25~L 
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2. Use the following PCR program: 
Initial denaturing 2 minutes at 94°C 
30 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 60°C 
Extension 40 seconds at 72°C 
Final Extension 5 minutes at 72°C 
3. Analyze product via agarose gel electrophoresis. A single 
product of 462bp should be amplified. 
Appendix 1.4: Protocols 
PCR 
Scott Leddon 
Department of Biological Sciences 
State University of New York College at Brockport 
Brockport, New York 
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Protocol 4.1 SOX TAE 
242g Tris base MW 121.1 
57.1rnL glacial acetic acid 
18.6g EDTA (disodiurn salt) MW 372.24 
1. Add the above to -900rnL diH20. 
2. pH to 8.3 with Tris base or glacial acetic acid. 
3. Volume to 1L with diH20. 
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Protocol 4.2 lX TAE 
1. Add 20mL of SOX TAE to 980mL of diH20. 
2. pH to 8.3 with Tris base or glacial acetic acid. 
Protocol 4.3 2.5% Agarose Gel (SOmL) 
1.25g agarose 
50mL TAE, pH 8.3 
1. Add the above to an 250mL Erlenmeyer flask (to minimize 
evaporation) . 
2. Heat in the microwave until agarose is fully dissolved, do 
not allow to over boil. 
3. Cool solution to 65°C, and under a fumehood add 5pL of 
lOmg/mL ethidium bromide. 
4. Mix well, pour into mold, and allow to set for 30 minutes 
at room temperature. 
5. Remove gel from mold, and place in electrophoresis chamber 
containing lX TAE. 
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Protocol 4.4 PCR Primer Dilutions 
Final concentration [DNA] 20pmole/J..1L 
((amount DNA in pmole) pmole · J..1L) I (20 pmole) 
DNase free H20]..1L 
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dilution of 
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Protocol 4.5 PCR Primer Temperature Optimization 
PFX PCR reaction mix (values given per reaction) 
2.50pL lOX buffer 
0.75pL lOmM DNTP 
0.50pL template 
0.20pL PFX 
19.05~L DNase free water 
0.50pL 50mM MgS0 4 
0.75~L 20pmole/~L forward primer 
0.75pL 20pmole/pL reverse primer 
TOTAL VOLUME 25pL 
1. Add all above components, except primers, and mix well. 6 
reactions per primer set will be needed. 
2. Split the reaction into the number of primer sets being 
assessed (23.5~L per reaction or 14lpL per primer set ) . 
3. Add 0.75pL of forward and reverse primer per reaction 
(4.5pL each per primer set) to the appropriate tubes and 
mix well. 
4. Split the reaction into 25pL volumes into thin walled PCR 
tubes. 
5. Run PCR program on temperature gradient, 48°C - 63°C. 
Initial denaturing 2 minutes at 94°C 
35 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 48- 63°C 
Extension 40 seconds at 68°C 
Final extension 5 minutes at 68°C 
6. Analyze PCR products by agarose gel electrophoresis. 
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Supermix PCR reaction mix (values given per reaction) 
23.00~1 Supermix 
0.50~1 template 
0.75~1 20pmole/~1 forward primer 
0.75~1 20pmole/~1 reverse primer 
TOTAL VOLUME 25~1 
1. Add all above components, except primers, and mix well. 6 
reactions per primer set will be needed. 
2. Split the reaction into the number of primer sets being 
assessed (23.5~1 per reaction or 141~1 per primer set ) . 
3. Add 0.75~1 of forward and reverse primer per reaction 
(4.5~1 each per primer set) to the appropriate tubes and 
mix well. 
4. Split the reaction into 25~1 volumes into thin walled PCR 
tubes. 
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5. Run PCR program on temperature gradient, 48°C- 63°C. 
Initial denaturing 2 minutes at 94°C 
35 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 48- 63°C 
Extension 40 seconds at 72°C 
Final extension 5 minutes at 72°C 
6. Analyze PCR products by agarose gel electrophoresis. 
163 
Protocol 4.6 2.5% Agarose Gel Electrophoresis 
1. Add SpL of 6X DNA loading buffer to 25pL of PCR reaction. 
2. Mix well. 
3. Load sample into agarose gel. 
4. Run gel at lOOmV for 2 minutes. 
5. Lower voltage to 70mV until desired separation is archived. 
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Protocol 4.7 PCR Primer Mg2+ Concentration Optimization 
It is ~ortant to note that Super.mix PCR can not be 
qptimized £or magnesium concentration because magnesium is 
part o£ the super.mix. 
Prepare the following solutions: 
4.166mM M~+ 
8.32pL 50mM MgS04 
91.68pL DNase free H20 
8. 333mM Mg2+ 
16.66pL 50mM MgS04 
83.33pL DNase free H20 
16. 666mM M~+ 
33.33pL 50mM MgS04 
66.66pL DNase free H20 
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PFX PCR reaction mix (values given per reaction) 
2.50pL lOX buffer 
0.75pL lOmM DNTP 
0.50pL template 
0.20pL PFX 
16.55pL DNase free water 
3. OOpL Mg 2+ solution 
0.75pL forward primer 
0.75pL reverse primer 
TOTAL VOLUME 25pL 
1. Add all above components, except primers and Mg2+ solution, 
for total number of reactions for all primer sets and Mg2+ 
concentrations (3 reactions per primer set) to be assayed 
and mix well. 
2. Split the reaction into three equal volumes, label the 
tubes 0.5, 1.0, and 2.0 (20.5pL X number of total 
reactions') /3 = division volume. 
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3. Add 3pL of 4.166rnM Mg 2+ per reaction to tube 0.5 (if 9 total 
reactions were set up, each of the split volumes should 
have 3 reaction volumes, so to 0.5 tube add 9pL of 4.166rnM 
Mg2+) and mix well. 
4. Repeat step 3 for tube 1.0 and 2.0 utilizing 8.333rnM Mg 2+ 
and 16.666rnM Mg 2+,respectively. 
5. Split each tube equally between the number of primer sets 
to be assayed. The volume per reaction of the tubes should 
be 23.5pL. 
6. Add proper forward and reverse primer volumes to each 
reaction tube (0.75pL of forward and reverse primer per 
reaction) and mix well. 
7. Split the reaction into 25pL volumes into thin walled PCR 
tubes. 
8. Run PCR program on optimized temperature 
Initial denaturing 2 minutes at 94°C 
35 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 48- 63°C 
Extension 40 seconds at 68°C 
Final extension 5 minutes at 68°C 
9. Analyze PCR products by agarose gel electrophoresis. 
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Protocol 4.8 General PFX PCR for Reverse Transcription 
Reaction 
1. Mix the following in a PCR tube: 
2.50pL lOX buffer 
0.75pL lOmM DNTP 
0.50pL template 
0.20pL PFX DNA polymerase 
19.05pL DNase free water 
0.25p1 50mM MgS04 (0.5mM final) 
0.75pL 20pmole/pL forward primer 
0.75pL 20pmole/pL reverse primer 
TOTAL VOLUME 25pL 
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2. Use the following PCR program: 
Initial denaturing 2 minutes at 94°C 
35 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 48- 63°C 
Extension 40 seconds at 68°C 
Final extension 5 minutes at 68°C 
4. Analyze product via agarose gel electrophoresis. 
5. Store reactions at -20°C until use. 
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Protocol 4.9 General Supermix PCR for Reverse Transcription 
Reaction 
1. Mix the following in a PCR tube: 
23.00~1 Supermix 
0.50~1 template 
0.75~1 20pmole/~1 forward primer 
0.75~1 20pmole/~1 reverse primer 
TOTAL VOLUME 25~1 
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2. Use the following PCR program: 
Initial denaturing 2 minutes at 94°C 
35 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 48- 63°C 
Extension 40 seconds at 72°C 
Final extension 5 minutes at 72°C 
6. Analyze product via agarose gel electrophoresis. 
7. Store reactions at -20 t until use. 
Appendix 1.5: Protocols 
DNA Sequencing 
Scott Leddon 
Department of Biological Sciences 
State University of New York College at Brockport 
Brockport, New York 
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Protocol 5.1 LB (Luria-Bertani) Ampicillin Media 
lOg tryptone 
Sg yeast extract 
lOg NaCl 
950mL deionized water 
1. Mix well and pH to 7.0 with l.OM NaOH. 
2. Bring final volume to lL with deionized water. 
3. Autoclave at 15psi for 20 minutes on liquid cycle. 
4. Allow to cool to about 55°C (this is when the solution 
can be held comfortably in hand) . 
5. Add O.lg of ampicillin (final concentration lOOpg/mL). 
6. Store at 4°C in the dark. 
172 
Protocol 5.2 LB (Luria-Bertani) Kanamycin Media 
lOg tryptone 
Sg yeast extract 
lOg NaCl 
950mL deionized water 
1. Mix well and pH to 7.0 with l.OM NaOH. 
2. Bring final volume to 11 with deionized water. 
3. Autoclave at 15psi for 20 minutes on liquid cycle. 
4. Allow to cool to about 55°C (this is when the solution 
can be held comfortably in hand) . 
5. Add 0.05g of kanamycin (final concentration SO~g/mL). 
6. Store at 4°C in the dark. 
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Protocol 5.3 LB (Luria-Bertani) Ampicillin Plates 
lOg tryptone 
5g yeast extract 
lOg NaCl 
950m1 deionized water 
1. Mix well and pH to 7.0 with 1.0M NaOH. 
2. Bring final volume to 11 with deionized water. 
3. Add 15g of agar. 
4. Autoclave at 15psi for 20 minutes on liquid cycle. 
5. Allow to cool to about 55°C (this is when the solution 
can be held comfortably in hand) . 
6. Add O.lg of ampicillin (final concentration 100pg/mL). 
7. Mix and then pour plates. 
8. Let plates harden. 
9. Store inverted at 4°C in the dark. 
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Protocol 5.4 LB (Luria-Bertani) Kanamycin Plates 
lOg tryptone 
Sg yeast extract 
lOg NaCl 
950mL deionized water 
1. Mix well and pH to 7.0 with l.OM NaOH. 
2. Bring final volume to lL with deionized water. 
3. Add lSg of agar. 
4. Autoclave at 15psi for 20 minutes on liquid cycle. 
5. Allow to cool to about 55°C (this is when the solution 
can be held comfortably in hand) . 
6. Add O.OSg of kanamycin (final concentration SOpg/mL). 
7. Mix and then pour plates. 
8. Let plates harden. 
9. Store inverted at 4°C in the dark. 
Protocol 5.5 PCR Reaction Purification 
1. Add 5X volume of Buffer PB to PCR reaction (5~1 of buffer to 
1~1 of PCR reaction). 
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2. Add sample to MinElute column (make sure column is in a 
collection tube). Maximum volume of MinElute column is 800~L, 
if samples exceed 800~L, repeat step 2 and 3 until all sample 
has been applied to column. 
3. Close MinElute column, centrifuge for 1 minute at 10,000 X g, 
and discard flow through. Reuse collection tube for step 4. 
4. Add 750~L of Buffer PE to the MinElute column, let stand 2- 5 
minutes 
5. Close MinElute column, centrifuge for 1 minute at 10,000 X g, 
and discard flow through. Reuse collection tube for step 6. 
6. Centrifuge for 1 minute at 10,000 X g, and discard flow 
through. Discard collection tube and place MinElute column in 
a new collection tube. 
7. Add 10~L of Buffer EB (10mM Tris·Cl, pH 8.5) or RNase Free H20 
to the membrane of the MinElute column. Let column stand for 
1- 2 minutes. 
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8. Close MinElute column, centrifuge for 1 minute at 10,000 X g. 
9. Store DNA at -20°C. 
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Protocol 5.6 Gel Extraction of Electrophoretically 
Separated DNA 
1. Cut DNA band of interest from gel, minimizing gel excised. 
2. Weigh gel in zeroed tube. 
3. Add 3X volume of Buffer QG to gel (1pg of buffer to 1mg of 
gel) for gels under 2%. For gels above 2% add 6X volume of 
Buffer QG to gel. If gel mass is above 400 mg, split sample 
into tubes of no more than 400 mg. 
4. Place tube with buffer and gel in 50°C H20 bath to dissolve 
gel. Vortex tube every 2 minutes, total incubation time 
should be about 10 minutes. Extend incubation if necessary 
until gel is fully dissolved. 
5. After gel is fully dissolved check the color of the buffer. 
If buffer is the original yellow color (color prior to 
incubation) proceed to step six. If the color of the buffer 
has changed from orange or violet add 10p1 of 3M sodium 
acetate, pH 5.0 and mix. The color of the solution should 
change back to yellow. 
6. Add one gel volume of isopropanol to sample (gel weight 
400mg add 400pL) and mix by inverting tube a few times. 
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7. Add sample to MinElute column (make sure column is in a 
collection tube) . Maximum volume of MinElute column is 
800pL, if samples exceed 800pL repeat step 7 and 8 until all 
sample has been applied to column. 
8. Close MinElute column, centrifuge for 1 minute at 10,000 X 
g, and discard flow through. Reuse collection tube for step 
9. 
9. Add 500pL of Buffer QG to the MinElute column. 
10. Close MinElute column, centrifuge for 1 minute at 10,000 X 
g, and discard flow through. Reuse collection tube for step 
11. 
11. Add 750pL of Buffer PE to the MinElute column, let stand 2-
5 minutes. 
12. Close MinElute column, centrifuge for 1 minute at 10,000 X 
g, and discard flow through. Reuse collection tube for step 
13. 
13. Centrifuge for 1 minute at 10,000 X g, and discard flow 
through. Discard collection tube and place MinElute column 
in a new collection tube. 
14. Add 10pL of Buffer EB (10mM Tris·Cl, pH 8.5) or RNase Free 
H20 to the membrane of the MinElute column. Let column 
stand for 1- 2 minutes. 
15. Close MinElute column, centrifuge for 1 minute at 10,000 X 
g. 
16. Store DNA at -20°C. 
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Protoco1 5.7 DNA Concentration 
1. Utilize 10mM Tris·Cl pH 7.5 to zero spectrophotometer. 
2. Dilute DNA 1:50 to 1:1000 in 10mM Tris·Cl pH 7.5, for 
absorbance values to be accurate the absorbance should be 
between 1.0- 0.15. 
3. Measure Az6o. 
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4. [DNA]llg/mL 50 X Az6o X dilution factor ( 1: 100 100) X Light 
path (em). 
5. DNA yield 11g [DNA]llg/mL X volume sample mL. 
Protocol 5. 8 DNA Purity (A2so/A2eo) 
1. Utilize 10mM Tris·Cl pH 7.5 to zero spectrophotometer. 
2. Dilute DNA 1:100 to 1:1000 in 10mM Tris·Cl pH 7.5, for 
absorbance values to be accurate the absorbance should be 
between 1.0- 0.15. 
3. Measure A26o and A2ao. 
4. Pure DNA has a A2 60 /A2ao ratio ranging from 1. 9- 2. 3. 
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Protocol 5.9 DNA Sequencing Reactions of PCR Products 
1. Purify PCR reactions by electrophoresis. 
2. Isolate DNA from gel. 
3. Calculate DNA concentrations and purity. 
4. Calculate minimum amount of DNA needed in ng (100 ng/~1 
maximum concentration) =length of PCR product (bp)/5.0. 
5. Add the calculated amount of DNA to sequencing tubes. 
6. Add 0.2~1 of 20pmole/~1 forward and reverse primers to 
sequencing tubes. 
7. Bring volume of reaction to 18~L with 10mM Tris, pH 9.0 or 
DNase free H20. 
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Protocol 5.10 TOPO Subcloning of Blunt end PCR products 
into Zeroblunt4PCR-TOPO Vector 
1. Prepare fresh PFX PCR reaction. 
2. Analyze products by gel electrophoresis ensure only one band. 
If more than one band purify band of interest. 
3. Add the following to a PCR tube: 
Fresh PCR reaction 0.5 to 4pl 
Topo salt solution lpl 
Sterile water add to final volume of 5pl 
TOPO vector lpl 
Final Volume 6pl 
4. Mix reaction gently and incubate at room temperature for 5- 30 
minutes (22-23"C). 
5. Place the reaction on ice. 
6. Proceed to transformation. 
Protocol 5.11 Transformation of TOPO Vector into 
Chemically Competent Cell 
1. Set up 42·c water bath. 
2. Warm S.O.C medium to room temperature. 
3. Warm two selective plates (LB 50pg/ml kanamycin or 
ampicillin) to 37•c for 30 minutes. 
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4. Thaw one vile of One Shot TOP10 chemical competent cells on 
ice per transformation. 
5. Add 2pl of TOPO reaction (from step 5) to one vial of cells 
and mix gently (no pipetteing) . 
6. Incubate on ice for 5- 30 minutes (incubation times seem not 
relevant to transformation optimization) . 
7. Incubate cells for 30 seconds at 42°C without shaking. 
8. Place tubes on ice. 
9. Transfer 250pl of S.O.C. medium to tube. 
10. Incubate tubes horizontally at 37°C for 1 hour with rotation 
(200rpm) . 
11. Spread 10- 50pl of transformation on prewarmed plates. For 
small volumes 20pl of S.O.C medium can be added prior to 
spreading to ensure uniform distribution. Two different 
concentrations should be plated to ensure well separated 
colonies. 
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12. Incubate plates at 37°C. Ampicillin plates take 8 hours and 
kanamycin plates incubate overnight. 
13. Good transformations should yield several hundred colonies. 
14. Pick ten well separated colonies and individual culture 
overnight at 37°C with rotation (200rpm) in 15ml of LB with 
50- 100pg/ml of ampicillin or 50pg/ml kanamycin. 
15. Inoculate a slant of LB with 50- 100pg/ml of ampicillin or 
50pg/ml kanamycin and incubate overnight before storage at 
4°C or glycerate and freeze cells at -80°C. 
16. Proceed to plasmid isolation. 
Transformation Control 
2. Set up 42·c water bath. 
3. Warm S.O.C medium to room temperature. 
4. Warm two selective plates (LB 100pg/ml ampicillin) to 37·c 
for 30 minutes. 
5. Thaw one vile of One Shot TOP10 chemical competent cells on 
ice per transformation. 
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6. Add 1pl of pUC19 10pg/pl to thawed cells. 
7. Incubate on ice for 5- 30 minutes (incubation times seem not 
relevant to transformation optimization) . 
8. Incubate cells for 30 seconds at 42°C without shaking. 
9. Place tubes on ice. 
10. Transfer 250pl of S.O.C. medium to tube. 
11. Incubate tubes horizontally at 37°C for 1 hour with rotation 
(200rpm) . 
12. Add 10pl of transformation to 20pl of S.O.C. medium, spread 
on prewarmed plates. 
13. Incubate plates at 37°C. Ampicillin plates take 8 hours or 
overnight. 
14. Good transformations should yield several hundred colonies. 
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Protocol 5.12 Plasmid Isolation from E. oo2i 
1. Make sure RNase A is added to Resuspention Buffer (R3) and 
was stored properly at 4°C. Confirm 100% ethanol was added 
to Wash Buffer (W9) and Wash Buffer (W10) . Check Lysis 
Buffer (L7) for precipitate, if precipitate is present heat 
at 60°C until dissolved. 
2. Pellet 1- 5pl of overnight culture of transforments. 
3. Decant media from pellet. 
4. Resuspend pellet in 250pl of Resuspention Buffer (R3), 
making sure no clumps remain (pipette up and down) . 
5. Add 250pl of Lysis Buffer (L7) and mix gently by inverting 
tube 5 times (no vortexing), if necessary warm buffer to 
37°C until salt dissolves (do not shake). 
6. Incubate for 5 minutes at room temperature (Do not exceed 5 
minutes). 
7. Add 350pl of Precipitation Buffer (N4) and mix immediately 
by inverting tube until the mixture is homogeneous (no 
vortexing) . 
8. Centrifuge at 12000 X g for 10 minutes at room temperature. 
9. Transfer supernate into spin column with wash tube, 
centrifuge at 12000 X g for 1 minutes at room temperature, 
and discard flow through. 
10. Add 500~1 of Wash Buffer (W10) to column, incubate for 1 
minute at room temperature, centrifuge at 12000 X g for 1 
minutes at room temperature, and discard flow through. 
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11. Add 700~1 of Wash Buffer (W9) to column, centrifuge at 12000 
X g for 1 minutes at room temperature, and discard flow 
through. 
12. Centrifuge at 12000 X g for 1 minutes at room temperature 
and discard flow through. 
13. Place spin column in recovery tube and add 75~1 of TE Buffer 
to the center of column. 
14. Incubate for 1 minute at room temperature and centrifuge at 
12000 X g for 2 minutes at room temperature. 
15. Analyze DNA for concentration by taking A260, purity by 
assessing the A260/A280 ratio (under 1.8 is good), and by 
restriction analysis and/or PCR to confirm integration of 
product of interest into TOPO vector. 
Protocol 5.13 PCR Verification of TOPO Subcloning 
1. Mix the following in a PCR tube: 
23.00~1 Supermix 
0.50~1 isolated plasmid 
0.75~1 20pmole/~1 Ml3 forward (-20) primer 
0.75~1 20pmole/~1 Ml3 reverse primer 
TOTAL VOLUME 25~1 
2. Use the following PCR program: 
Initial denaturing 2 minutes at 94°C 
35 cycles of the following: 
Denaturing 20 seconds at 94°C 
Annealing 30 seconds at 55°C 
Extension 40 seconds at 72°C 
Final extension 5 minutes at 72°C 
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3. Analyze product via agarose gel electrophoresis. Expected band 
size is 162bp + length of predicted insert. 
4. Store reactions at -20°C until use. 
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Protocol 5.14 DNA Sequencing Reactions of PCR4Blunt-TOPO 
Vectors Utilizing M13 Universal Primers 
1. Prior to sequencing plasmid DNA must be isolated from 
overnight bacterial culture and then subjected to verification 
of subcloning. 
2. Add lpg of plasmid DNA to a SOOpl screw cap vial. 
3. Add 8pmole of Ml3 forward or reverse primer (not both). 
Primers are also available from sequencing facilities. 
4. If utilizing in house Ml3 primers bring reaction volume to 
18pl with molecular biology grade water. If utilizing 
sequence facility supplied primers bring the reaction volume 
to lOpl with molecular biology grade water. If reaction 
exceeds final volume before the addition of water then 
lyophilize sample and reconstitute with molecular biology 
grade water to indicated final reaction volume. 
5. Overnight samples to DNA sequencing facilities, no 
refrigeration is necessary for DNA samples. 
6. Blastn results to confirm subcloning. 
Appendix 2: Immunohistochemistry 
Scott Leddon 
Department of Biological Sciences 
State University of New York College at Brockport 
Brockport, New York 
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Appendix 2: Immunohistochemistry 
Appendix 2.1: ICC Staining of the Zebrafish 
Gastrointestinal Tract 
Kit Immunohistochemistry 
Longitudinal Section of Gastrointestinal Tract 
Anterior 
Anterior 
Middle 
Middle 
Middle 
Posterior 
Posterior 
Posterior 
Mag. 
20X 
40X 
20X 
40X 
100X 
20X 
40X 
sox 
Page 
196- 197 
198- 199 
200- 205 
206- 209 
210 
211- 213 
214- 216 
217 
Appendix 2.2: ICC and Neuronal Cell Body Dual Staining 
of the Zebrafish Gastrointestinal Tract 
Kit and HU C/D Dual Immunohistochemistry 
Longitudinal Section of Gastrointestinal Tract Mag. 
Anterior 20X 
Anterior 40X 
Middle 20X 
Middle 
Posterior 
Posterior 
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40X 
20X 
40X 
Page 
218 
219 
220 
221 
222 
223 
_Appendix 2.3: ICC and Neuronal Process Dual Staining of 
the Zebrafish Gastrointestinal Tract 
Kit and a-Tubulin Dual Immunohistochemistry 
Longitudinal Section of Gastrointestinal Tract Mag. 
Anterior 20X 
Anterior 40X 
Middle 20X 
Middle 40X 
Posterior 20X 
Posterior 40X 
Appendix 2.4: ICC and Smooth Muscle Dual Staining 
the Zebrafish Gastrointestinal Tract 
Kit and Desmin Dual Immunohistochemistry 
Longitudinal Section of Gastrointestinal Tract 
Anterior 
Anterior 
Middle 
Middle 
Posterior 
Posterior 
Mag. 
20X 
40X 
20X 
40X 
20X 
40X 
Appendix 2.5: Immunohistochemistry Controls of the 
Zebrafish Gastrointestinal Tract 
Control Description 
CY3 2° Ab Bleed Through into CY5 Channel Control 
Anti-Kit Cross Reactivity with Anti-Desmin, Anti-HU-C/D, and 
Anti-a-Tubulin 2° Ab Control 
CY5 2° Ab Bleed Through into CY3 Channel 
195 
Mag. 
40X 
40X 
40X 
Page 
224 
225 
226 
227 
228 
229 
of 
Page 
230 
231 
232 
233 
234 
235 
Page 
236 
237 
238 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Anterior, CY3 Filter 
196 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Anterior, CY3 Filter 
197 
Anti - kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Anterior, CY3 Filter 
198 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Anterior, CY3 Filter 
199 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter 
200 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter 
201 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter 
202 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter 
203 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter 
204 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter 
205 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter 
206 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter 
207 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter 
208 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter 
209 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
lOOX Middle, CY3 Filter 
210 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Posterior, CY3 Filter 
211 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Posterior, CY3 Filter 
212 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Posterior, CY3 Filter 
213 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Posterior, CY3 Filter 
214 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Posterior, CY3 Filter 
215 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Posterior, CY3 Filter 
216 
Anti-kit Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
SOX Posterior, CY3 Filter 
217 
Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Anterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-HU C/D, bottom) 
218 
Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Anterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-HU C/D, bottom) 
219 
Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-HU C/D, bottom) 
220 
Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-HU C/D, bottom) 
221 
Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
222 
20X Posterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-HU C/D, bottom) 
Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
223 
40X Posterior, CY3 Filter (Anti-kit, top), 
CY5 Filter (Anti-HU C/D, bottom) 
Anti-kit and Anti-a-tubulin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Anterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-a-tubulin, bottom) 
224 
Anti-kit and Anti-a-tubulin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Anterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-a-tubulin, bottom) 
225 
Anti-kit and Anti-a-tubulin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-a-tubulin, bottom) 
226 
Anti-kit and Anti-a-tubulin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-a-tubulin, bottom) 
227 
Anti-kit and Anti-a-tubulin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
228 
20X Posterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-a-tubulin, bottom) 
Anti-kit and Anti-a-tubulin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Posterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-a-tubulin, bottom) 
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Anti-kit and Anti-desmin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Anterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti - desrnin, bottom) 
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Anti-kit and Anti-desmin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Anterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-desmin, bottom) 
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Anti-kit and Anti-desmin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Middle, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-desmin, bottom) 
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Anti-kit and Anti-HU C/D 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Middle, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-desmin, bottom) 
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Anti-kit and Anti-desmin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
20X Posterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti-desmin bottom) 
234 
Anti-kit and Anti-desmin 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
235 
20X Posterior, CY3 Filter (Anti-kit, top), 
CYS Filter (Anti - desmin, bottom) 
CY3 2° Bleed Through Control 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
236 
40X Distal, CY3 Filter (Anti-kit, top), CYS 
Filter (bottom) 
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Anti-kit Cross Reactivity with Anti-desmin, HU-
C/D, a-tubulin 2° Antibody Control 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Distal, CY3 Filter (Anti-kit, top), CYS 
Filter (bottom) 
CYS 2° Bleed Through Control 
Immunohistochemistry 
Zebrafish Gastrointestinal Tract 
40X Distal, CY3 Filter (top), CYS Filter 
(Anti-desmin bottom) 
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RNA Integrity and Uniform eDNA Synthesis 
()3I()2J2()00 
Scott Leddon 
Gel1 
11% FA 1XAgarose Gel 
Goa~ Detennine if the integrity of total Gl RNA is suitable for 
da.Ynstream applications. Degradation/lack of rRNA indicates 
compromised RNA integrity. 
Results 
.-.si 
T ~ Gl RMo\ Eipdllllalq 1rilmfiir 28s, 26s, lllll!i rRMo\ 
T ~ Gl dJI. ~ rRMo\ llnls, idaEs lid ~ Cllillriacr1 
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exH:TQm T~VUsh T~Mliih T~Mliih orH:TGn! 
~,. RMo\ dJI. RMo\ 1~ IU{ 
~!.a* ~!.a* 
• 'lli •oo 
' II' ~ 
' I» ~ 
• '1) ~ 
, ~ IC 
• j)j ~ 
• I)) Q 
RT-PCR 
211412000 
Scollleddon 
Gel1 Bioline 
HyperladderiV 62.1'C 62.0't III.II'C 58.3'C 56.3'C 54.4'C 52.4'C 91.1'C 49.3'C 411.~ 411.1,; 
1.0 rMf UgS04 
2.0% T AE 1X Agarose Gel 
Goa~ T ~lure ~lililatioo 
of 18sRNA92 priner set 
Results 
~ ()i!!Bmap Te!!pnUe 
1~ Expii:BIIIni54.4'C- 411.1'C 
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RT-PCR 
03lll8f2006 
Scott Leddon 
Gel2 
O.Sni.f MgS04 
2.5% TAE 1XAgaroseGel 
Gael-Priner T 1!f111e!alure 
~tilization 
~ ~ 
63.2"C 54.4'C 
~ ~197rt 
~ 411.!fC lll.6'C ~g7rt 
62.0"C 
~ ~ 
58.3'C ~.1'C 
Results 
52.3'C ~197rt 
411.1"C 
~97rt 
~197rt ~197rt 
62.1'C 56.3'C 
49.3'C 
~ O!ln81rnl*l! Jenprabe 
KilaR.lM 63.2"C -54.4' C, 21Jfdds-lifjln1Binj _. 
may ll!rmled 
~97rt 62.1'C- 56 .J'C 
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RT-PCR 
0310812006 
Saltt L.eddon 
Gel4 
0.5n#A MgS04 
2.5% TAE 1XAgaroseGel 
Goll-Priner T ~lure 
~lilization 
18srRtWI2 
/ ..... \ 
63.2'C 
91.7"C 
~'\. 
52.4"C 4B.rc 
49.3"C 
!ii3"C 
~ QWnBMI!Bn! IfmlmVe 
F2_R17 62.7"C - 9i .3"C 
18srRtWI2 
63.2'C I 
' IMsUies~ ~ leqaaUes, !Uiis~st..s • 
18srRtWI2 raPes~= tnt.l 
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!CO II 
210 11 
1011 !! 
150 )l 
100 II 
50 II 
RT-PCR 
0310812006 
Sc:oll Leddon 
Gel3 
0.5~Mg504 
2.5% TAE 1XAgaroseGel 
Goii-Priner T eqmture 
~lirizalion 
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er/CfQm /Zish_til_1"" ~~ / ~~ erH:TQm 1~ ~ Wbp ~Iii 
~~ t ~~ 
48.1'C / 48./fC 62.l"C 52 4 'C 
62.l"C /62.0'C · 48.1'C 
49.3 'C 63.2"C :il.l"C 
tll.6'C 49.3'C 
lllll<""" 
• lim!((' Results !)) 1J 
·- Ill!) 
•· ':II r. ~ Qi!MhnBIIJ Tenpr;Ue 
ill ' 
.... !\XI ~ ~ 62.l"C- tll.II'C 
10) ~ ~415 632' c-58.3' c 
~ :m It Zlsh_til_1 62.l"C- 48 .1'C 
• '!1! ~ Zlsh_til_2 632'C - 4l!fC 
~ 62.l"C- 48.1'C 
'1J ~ F2_R13 48./fC- 21815rlilll leMa'~~ lillY be rmBI 
... 
RT-PCR 
~ 
Scott Leddon 
Gel1 
O.Snt MgS04 
PCRSUPERMIX 
2.5% TAE 1X AgaroseGel 
Goll-Priner T errpemure 
~tirizaliln 
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=l-l l-l ~~-"-'l =~ 
""' """ .. "' ""' """ .. "' """ • .., .. "' j 
Results 
. .. . BiDIISi ~IIBMB!Iug T.;Ue 
• ¥0 &,; 
• w ' 
~ llll"C- 11.5' c 
• n· a 
~ !0.1'C , .. 
ZFJil_2 11.5C- !0.1' C .. . 
. .. ' .. 
.. 
RT-PCR 
IW26I2006 
Scott Leddon 
Gel1 
O.SmMMgS04 
PFX DNA Polymelase 
2.5% TAE 1XAgaroseGel 
Goei-Priner T ~re~lilizalion 
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,. .... 
RT-PCR 
0212012006 
Scott Leddon 
Gel1 
1.0nHMgS04 
2% TAX 1x~roseGel 
Goai-T~re 
~ofkitbr234 
prinerset. 
lildl234 Iild!234 
633'C 62.9'C 
lildl234 Iild! 234 
53.Tc S6.rc 
Bll234 
41.5'C 
elACI'Gele )~ Ccdol(-) 
JlaOOUdd!J 41l'C Collrol(-) 
IIIKIIA S0.6'C 
S0.6'C IIIKIIA 
4U'C 
lildl234 Iild!234 
61.tC 60.4'C 
Results 
Eqa:BIImi63.3'C - 48.1'C 
Iild!234 Bll234 
j4J'Clild!234 49.4'C 
ru'C 
Bll234 
S0.6'C 
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RT-PCR 
02/24f2006 
Sallt Leddon 
Gel2 
1.0 rMt MgS04 
2.5% TAE 1XAgarose Gel 
Goai-T~re 
~ti!izalion ofkitbr118 and 
kitarSO pmset. 
~ ~18 
.4'C ~ ~48. ~ 56.8'C 62.9'C 
~ 52.2'C 
48.1•c 
~ 
111.4'C 
~11118 
52.2'C 
~118 
«1.4'C 
~18 
56.8'C 
~ Qinllm!ln! Tenprain 
~18ar.ICTGn 
62.9'C ~~ 
11*118 ~L* 
111.4'C 
II!Xl 100 
OCXl 
a)) 8) 
100 10 
8)0 Ill 
lOO 10 
lOO 10 
~ Falalal It 1em,BBUes,lam rd ~ si2es 
~118 Eqa:BIIam 52.2"C- 62.9'C 
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RT-PCR 
0310812006 
Scott Leddon 
Gel1 
O.Sn#.f Mg504 
2.5% TAE 1XAgaroseGel 
Goii-Priner T en~rcllure 
~li!ization 
Q) () 
)'.0 :rJ 
lOO 20 
•!J) () 
--
~1&\ 
63.2"C 
~ 
~~&I 
IWlRlll 
~&I 
91.7'C 
Results 
~ 
lii.&'C 
~ 
62.7'C 
Qllnah•m IQ!!Il!llM 
63.2"C -~ .1C 
62.7'C - !ii .1C 
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t1.1•c 
RT-PCR 
2.5% TAE 1XAgaroseGel 
Goal-T efT1le~Cilure 
~tmzation of kital650 and 
kital470 priner set. 
. ... 
... 
.. " 
.. . 
10 • 
~ ~ 
Ill_ 4" c 52.2" c 
~ 
~ !ii.8'C 
62.9"C 
~ 
48.1C 
~ Kii!L4111 
49.4"C 63.3'C 
Kii!L4111 
58.7'"C 
Kii!L4111 
61.8'C 
Kii!L4111 
KiiiL 4111 91.8' c 
54.1"C 
~ O!INtmBn! lenmaUe 
~ Exja:ted llniiii.4'C- 48.1'C 
KiiiL 4111 Exja:ted llnl 51. 4'C - 48.5'C 
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RT-PCR 
03lll8I2(Di 
Saltt leddon 
Gel4 
O.SnH MgS04 
2.5% TAE 1XAgaroseGel 
Goii-Priner T ~re 
~tmtion 
~ 
~ 
. 
18srRNI\92 
•• I; ~ 100 Ill 
' 00 ao F2_R17 
m .., 
~4«) 
IOC lO 
~ 18srRNI\92 
... , 
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~\ 
52.4'C 411.1'C 
49.3'C 
MmitmrQ I!!!!pDUe 
210 II 
62.7"C - !ii .3'C liiO IS 
1!0 ll 
63.2'C l 100 It 10 K 
' lmsUies·llilm~ . !Utis~st.E i ll II 18srRNI\921l1Pes~ = 1nill I 
RT-PCR 
~16J2006 
Scott Leddon 
Gelt 
0.5mMMgS04 
PFX DNA Polymerase 
2.5% TAE tX~roseGel 
Goal-Rerun of cloning priners b" poster and 
p!JIIicatioo 
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erH:TQm ~ ~ ~ F2-R11~) jl-ld'1 
~ .. DW!l.dr 61.8'C 51'C 61.8'C 61.8'C 61.8'C 
j j j j j j 
Results 
RT-PCR 
0311412006 
Scott Leddon 
Gel1 
0.5rr#.t MgS04 
2.5% TAE 1XAgaroseGel 
Goii-PCR b DNA sequencing 
e«TGn er!CTGn 
~Mri 1~PCR 
DNA~ DNA~ jkd1 
-
Results 
ltlfinrsels ,aiBd elpiEiad si2BI 
lfllb:tsvtB:h t~rg~t om .u m ga 
nl flM!til1c;t~Jm niri ... til 
F2R17 
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It 
ll 
" II 
II 
11 
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RT-PCR 
~ 
Scollleddon 
Gel1 
0.5"" Mg504 
PFX OM Po1ymeriise 
2.5% TAE 1XAgaroseGel 
Gal~ ~ibtiln of targets ilr insertion into 
TOP04PCRBiunt Vectors ilrsequendrG 
.,. .. 
Zf _Iii_ 2 l'iRii4 (lfm) 
62'C 
Results 
~ .f.lnlm 
~21m! 
~21m! 
Nlal., be lllllllilllllll! !». 
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RT-PCR 
0510312006 
Scott Leddon 
Gel2 (rerun gel1) 
0.5mMMgS04 
PfX DNA Po1yrne1ise 
2.5% TAE 1XAgaroseGel 
Goii-Ar!111ification of targets tor insertion into 
TOP04PCRBiunt Vectors tor sequend~ 
• ,. r 
• '.1) t; 
~ 
lll.J'C 
I 
~ 
ZFJi1_2 
If <»>f 
256 
exi£TG1111 
Zftil 2 ~ (VR) !BlpMri 
- - IW. t.kllf 
62'C 58.3'C 
I \ 
Results 
f.!m!IDs 
~si2elml 
~lints 
...... 
II 
" 
" 
RT-PCR 
~ 
Scott Leddon 
Gel1 
O.S!Mt Mg504 
PFX DNA Pol)merase 
2.5% TAE 1X~Gel 
w~ ottargetswinsertion 
into TOP04PCRBiunt Vectors w 
~IVJ 
62't 54.fC :il.1"C 
~; 1; Results 
. ' 
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e«TGEre 
~.­
...... ~G)\ lfltim4. ~I.DIIJ 
62't 54.fC :il.1"C J II2'C 54.fC 
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RT-PCR 
~10f2Wi 
Scott Leddon 
Gel1 
O.Sn#.t Mg504 
PCRSlPERMIX 
2.5% TAE 1X~roseGel 
WGel was run on TOP04PCRBiunt 
Vectors with insert. Priners were M13 
Results 
~~ 
AI~ ~WJ! fin! b-53'1: 
~ Zf Jil_2 ~ F2-R17 F2-R17 Zf _ ij _2 
(](m 10 (](m 4 (](m 3 (](m 4 (](m 9 (](m 5 
53'C 
Zf lit 2 e«TGIJI! 
-- ~ .. 
lllm2 !HI!*" 
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Conformation of 
Insert for Sequencing 
~7fm 
Scntleddon 
Gel1 
0.51Mt Mg504 
PCRSUPERMIX 
2.5% TAE 1XAgaroseGel 
Goii-Gel was !Ill on T~ 
VedO!Swith insert. PrinerswereM13. To 
calcula!expec:Ed PCR productsi21! mn 
priring ofT<Jl04PCRBiurt Vedors add 
1~ to the si21! of the insert. 
Results 
~ Qjn8fmiQ lqlrU 
,.. ~sill!llnlb"!'eC 
BiliiSid 
M13 62.3"C - 48.5' c 
259 
erN:TGn 
l®i5lll ~ KiWI) l®t5!l KiWII l®t5!l _ .. 
r lllm48 1 r ~ 1 r acmt 1 r lb1etf 1 r (]emf 1 r IbM: l(H.l.li*J 
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